Processing 00000000.tx.1: The New Antidiabetic Drug MCC-555 Acutely Sensitizes Insulin Signaling in Isolated Cardiomyocytes1 Li Sen Liu, Hideho Tanaka, Shinichi Ishii and Jrgen Eckel Molecular Cardiology, Diabetes Research Institute, Dsseldorf, Germany; 

Phrase: "The New Antidiabetic Drug MCC-555 Acutely"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   827   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   827   C0935929:antidiabetic drug [Pharmacologic Substance]
           antidiabetic
   799   C0013227:Drug [Pharmacologic Substance]
   799   C0205314:New [Temporal Concept]
   799   C1254351:Drug [Pharmacologic Substance]
   743 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   743 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   706 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "Sensitizes"

Phrase: "Insulin Signaling in Isolated Cardiomyocytes1 Li Sen Liu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]

Phrase: "Hideho Tanaka,"

Phrase: "Shinichi Ishii"

Phrase: "and"

Phrase: "Jrgen Eckel Molecular Cardiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0007189:Cardiology [Biomedical Occupation or Discipline]
   812   C1555719:Cardiology [Idea or Concept]

Phrase: "Diabetes Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Dsseldorf,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ";"
Processing 00000000.tx.2: and Mitsubishi Chemical Co. 

Phrase: "and"

Phrase: "Mitsubishi Chemical Co."
Processing 00000000.tx.3: (H.T., S.I.), Yokohama, Japan Address all correspondence and requests for reprints to: Prof. 

Phrase: "(H.T.,"

Phrase: "S.I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "Yokohama,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Prof."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599518:Prof. [Professional or Occupational Group]
Processing 00000000.tx.4: Dr. 

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.5: Jrgen Eckel, Diabetes Research Institute, Aufm Hennekamp 65, D-40225 Dsseldorf, Germany. 

Phrase: "Jrgen Eckel,"

Phrase: "Diabetes Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Aufm Hennekamp 65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450385:65 [Intellectual Product]

Phrase: "D-"

Phrase: "40225 Dsseldorf,"

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.6: E-mail: eckel{at}uni-duesseldorf.de  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Freshly isolated adult rat ventricular cardiomyocytes have been used to characterize the action profile of the new thiazolidinedione antidiabetic drug MCC-555. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "eckel{at}uni-duesseldorf.de  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Freshly isolated adult rat ventricular cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0225828:Cardiomyocytes [Cell]

Phrase: "have"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the action profile of the new thiazolidinedione antidiabetic drug MCC-555."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1979963:Profile [Laboratory Procedure]
   738   C2003903:Profile [Functional Concept]
Processing 00000000.tx.7: Preincubation of cells with the compound (100 M for 30 min or 10 M for 2 h) did not modify basal 3-O-methylglucose transport, but produced a marked sensitizing effect (2- to 3-fold increase in insulin action at 3 x 10-11 M insulin) and a further enhancement of maximum insulin action (1.8-fold). 

Phrase: "Preincubation of cells"

Phrase: "with the compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "(100 M for 30 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "or"

Phrase: "10 M for 2 h)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2348952:H/m [Quantitative Concept]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "basal 3-O-methylglucose transport,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005528:Transport, NOS [Cell Function]
   804   C1317949:Transport [Manufactured Object]
   804   C3495449:transport [Medical Device]

Phrase: "but"

Phrase: "produced"

Phrase: "a marked sensitizing effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "(2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 3-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "in insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "at 3 x 10-11 M insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "a further enhancement of maximum insulin action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   748   C2349975:Enhancement [Activity]

Phrase: "(1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.8: MCC-555 did not modulate autophosphorylation of the insulin receptor and tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1). 

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "autophosphorylation of the insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0813988:autophosphorylation [Molecular Function]

Phrase: "and"

Phrase: "tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.9: However, insulin action (10-10 and 10-7 M) on IRS-1-associated phosphatidylinositol (PI) 3-kinase activity was enhanced 2-fold in the presence of MCC-555. 

Phrase: "However,"

Phrase: "insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10-10"

Phrase: "and"

Phrase: "10-7"

Phrase: "M)"

Phrase: "on IRS-1-associated phosphatidylinositol (PI) 3-kinase activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   895   C1150623:insulin receptor activity [Molecular Function]
   891   C1145751:insulin activity [Molecular Function]
   879   C1152633:receptor activity [Molecular Function]
   849   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   834   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   807   C1150423:kinase activity [Molecular Function]
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   711   C2350410:Insulin Receptor Substrate-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "2-fold in the presence of MCC-555."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332462:Fold [Spatial Concept]
   744   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.10: Association of the p85 adapter subunit of PI 3-kinase to IRS-1 was not modified by the drug. 

Phrase: "Association of the p85 adapter subunit of PI 3-kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "to IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modified by the drug."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0205349:Modified By [Qualitative Concept]
   770   C0013227:Drug [Pharmacologic Substance]
   770   C0392747:Modified [Functional Concept]
   770   C1254351:Drug [Pharmacologic Substance]
   715 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   715 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
Processing 00000000.tx.11: Immunoblotting experiments demonstrated expression of the peroxisomal proliferator-activated receptor- in cardiomyocytes reaching about 30% of the abundance observed in adipocytes. 

Phrase: "Immunoblotting experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "expression of the peroxisomal proliferator-activated receptor-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "reaching about 30% of the abundance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C2346714:Abundance [Qualitative Concept]
   753   C2584321:Reaching [Organism Function]

Phrase: "observed in adipocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0206131:Adipocytes [Cell]
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.12: The insulin-sensitizing effect of MCC-555 was lost after inhibition of protein synthesis by preincubation of the cells with cycloheximide (1 mM; 30 min). 

Phrase: "The insulin-sensitizing effect of MCC-555"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "lost after inhibition of protein synthesis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   820   C1519619:Protein Synthesis Inhibition [Genetic Function]
   790   C0597295:Protein Synthesis [Molecular Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220781:synthesis [Biologic Function]
   753   C0745777:Lost [Functional Concept]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C1883254:Synthesis [Activity]
   753   C3463820:Inhibition [Activity]
   748 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "by preincubation"

Phrase: "of the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "with cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(1 mM"

Phrase: "; 30 min)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.13: Cardiomyocytes from obese Zucker rats exhibited a completely blunted response of glucose transport at 3 x 10-11 M insulin. 

Phrase: "Cardiomyocytes from obese Zucker rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0225828:Cardiomyocytes [Cell]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a completely blunted response of glucose transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "at 3 x 10-11 M insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.14: MCC-555 ameliorates this insulin resistance, producing a 2-fold stimulation of glucose transport, with maximum insulin action being 1.6-fold higher than that in control cells. 

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "ameliorates"

Phrase: "this insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "producing"

Phrase: "a 2-fold stimulation of glucose transport,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C2259160:stimulation of transport [Cell Function]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with maximum insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441472:Action [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C3266814:Action [Activity]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "being"

Phrase: "1.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in control cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.15: This drug effect was paralleled by a significant dephosphorylation of IRS-1 on Ser/Thr. 

Phrase: "This drug effect"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0728866:Drug effect [Functional Concept]
  1000   C0728867:Drug effect [Pathologic Function]
  1000   C1411996:drug effect [Biologic Function]
   861   C0013227:Drug [Pharmacologic Substance]
   861   C1254351:Drug [Pharmacologic Substance]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "was"

Phrase: "paralleled by a significant dephosphorylation of IRS-1"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   806   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   760   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   760   C1334133:INSULIN RECEPTOR [Gene or Genome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0237881:significant [Quantitative Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0750502:Significant [Idea or Concept]
   739   C1158884:Dephosphorylation [Molecular Function]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1546944:Significant [Qualitative Concept]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1710236:Substrate [Manufactured Object]
   739   C3160734:Dephosphorylation [Molecular Function]
   706   C2348042:Parallel [Qualitative Concept]
   706   C2826345:PARALLEL [Research Activity]

Phrase: "on Ser/Thr."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.16: In conclusion, MCC-555 rapidly sensitizes insulin-stimulated cardiac glucose uptake by enhancing insulin signaling resulting from increased intrinsic activity of PI 3-kinase. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "MCC-555 rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   827   C1637379:Rapidly [Qualitative Concept]

Phrase: "sensitizes"

Phrase: "insulin-stimulated cardiac glucose uptake by enhancing insulin signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1159527:glucose uptake [Cell Function]
   762   C1719133:Glucose/Insulin [Quantitative Concept]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0243144:Uptake [Physiologic Function]
   742   C0347980:% uptake [Quantitative Concept]

Phrase: "resulting from increased intrinsic activity of PI 3-kinase."
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   810   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   790   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   781   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   762   C0474395:increased activity [Finding]
   762   C1150423:kinase activity [Molecular Function]
   762 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205102:Intrinsic [Spatial Concept]
   742   C0205177:Activity [Functional Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0439674:Intrinsic [Functional Concept]
   742   C0441655:Activity [Activity]
   742   C0442805:Increased [Functional Concept]
   742   C0678226:resulting [Functional Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C2348046:Phosphatidylinositol [Lipid]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]
Processing 00000000.tx.17: Acute activation of protein expression leading to a modulation of the Ser/Thr phosphorylation state of signaling proteins such as IRS-1 may be underlying this process. 

Phrase: "Acute activation of protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0599177:protein activation [Genetic Function]
   760   C1879547:Activation [Activity]

Phrase: "leading to a modulation of the Ser/Thr phosphorylation state of signaling proteins"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   735   C0031715:Phosphorylation [Molecular Function]
   735   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0037083:Signaling [Cell Function]
   735   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   735   C0332152:Leading [Temporal Concept]
   735   C0443264:Modulation [Spatial Concept]
   735   C1158886:Phosphorylation [Molecular Function]
           Protein phosphorylation
   735   C1301808:State [Geographic Area]
   735   C1442792:State [Functional Concept]
   735   C1522538:Leading [Functional Concept]
   735   C3148680:State [Geographic Area]
   735   C3537152:signaling [Biologic Function]
   733   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   732   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   702 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   702 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   702 E C1710082:Signal [Phenomenon or Process]
   702 E C2348269:Lead [Element, Ion, or Isotope]
   702 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "such as IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "underlying"

Phrase: "this process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.18: It is suggested that MCC-555 may provide a causal therapy of insulin resistance by targeted action on the defective site in the insulin signaling cascade.  

Phrase: "It"

Phrase: "is"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a causal therapy of insulin resistance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0039798:therapy [Functional Concept]
   753   C0087111:Therapy [Therapeutic or Preventive Procedure]
   753   C1363945:Therapy [Finding]

Phrase: "by targeted action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441472:Action [Functional Concept]
   861   C3266814:Action [Activity]

Phrase: "on the defective site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "in the insulin signaling cascade."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2611812:signaling cascade [Cell Function]
   827   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.19: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  THE THIAZOLIDINEDIONES (TZD) represent a new family of orally active antidiabetic drugs that increase the insulin sensitivity of all target tissues (for review, see Refs. 1, 2). 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "THE THIAZOLIDINEDIONES (TZD)"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a new family of orally active antidiabetic drugs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015576:Family [Family Group]
   744   C1704727:Family [Conceptual Entity]

Phrase: "that"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the insulin sensitivity of all target tissues"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0920563:Insulin Sensitivity [Pathologic Function]
   757   C0234235:Tissue sensitivity [Sign or Symptom]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "("

Phrase: "for review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Refs. 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332102:REF-1 [Gene or Genome]
   861   C1425988:REF [Gene or Genome]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: A variety of studies in genetic (3, 4) and nongenetic (5) rodent models of insulin resistance have confirmed that these compounds reduce plasma glucose, insulin, and triglyceride levels. 

Phrase: "A variety of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "in genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")"

Phrase: "and"

Phrase: "nongenetic"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "rodent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodent [Mammal]

Phrase: "models of insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3161035:Model [Intellectual Product]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "have"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "these compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "reduce"

Phrase: "plasma glucose,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0202042:Plasma glucose [Laboratory Procedure]
  1000   C0455280:plasma glucose [Laboratory or Test Result]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "triglyceride levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428475:Triglyceride level [Laboratory or Test Result]
   861   C0041004:Triglyceride [Biologically Active Substance,Lipid]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.21: However, TZD are ineffective in euglycemic animals; 

Phrase: "However,"

Phrase: "TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "are"

Phrase: "ineffective in euglycemic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3242229:ineffective [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.22: thus, the induction of hypoglycemia does not occur (2). 

Phrase: "thus,"

Phrase: "the induction of hypoglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.23: In vivo, insulin sensitizing was shown to increase glucose disposal and reduce hepatic glucose output in rodent models of insulin resistance (6, 7). 

Phrase: "In vivo, insulin sensitizing"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "glucose disposal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707797:Disposal [Activity]

Phrase: "and"

Phrase: "reduce"

Phrase: "hepatic glucose output in rodent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0599782:glucose output [Organ or Tissue Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205054:Hepatic [Body Location or Region]
   760   C1709366:Output [Conceptual Entity]

Phrase: "models of insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3161035:Model [Intellectual Product]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.24: In vitro, TZD increase glucose uptake and glucose transporter expression in adipocytes (8) and myocytes (9) and inhibit gluconeogenesis in hepatocytes (10). 

Phrase: "In vitro, TZD increase glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1159527:glucose uptake [Cell Function]
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   799   C0243144:Uptake [Physiologic Function]
   799   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "glucose transporter expression in adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(8"

Phrase: ")"

Phrase: "and"

Phrase: "myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596981:Myocytes [Cell]

Phrase: "(9"

Phrase: ")"

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "gluconeogenesis in hepatocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017715:Gluconeogenesis [Molecular Function]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.25: Clinical trials have confirmed the efficacy of TZD for the treatment of NIDDM patients (for review, see Ref. 2). 

Phrase: "Clinical trials"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008976:Clinical Trials [Research Activity]
           Trial
  1000   C1096775:clinical trials [Intellectual Product]
   861   C0205210:Clinical [Qualitative Concept]

Phrase: "have"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the efficacy of TZD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:Efficacy [Qualitative Concept]
   770   C1707887:EFFICACY [Research Activity]

Phrase: "for the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of NIDDM patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "("

Phrase: "for review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.26: Further, the drugs may also be suitable for treatment of nondiabetic insulin-resistant states such as obesity (11), the polycystic ovarian syndrome (12), and Werners syndrome (13). 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "suitable for treatment of nondiabetic insulin-resistant states"

Phrase: "such as obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "the polycystic ovarian syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032460:Polycystic Ovarian Syndrome [Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Werners syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043119:Werners Syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.27: Despite their high impact on the future treatment of insulin-resistant patients, the molecular pathways of TZD action have remained poorly understood. 

Phrase: "Despite their high impact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1825598:IMPACT [Gene or Genome]

Phrase: "on the future treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "of insulin-resistant patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "the molecular pathways of TZD action"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1704259:molecular pathway [Molecular Function]
           Pathways
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "have"

Phrase: "remained"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.28: At least three different models may be considered. 

Phrase: "At least three different models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Models [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "considered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]
Processing 00000000.tx.29: 1) Convincing evidence supports the idea that the transcription factor peroxisomal proliferator-activated receptor- (PPAR) represents the intracellular receptor for TZD action (14), with the in vivo efficacy of TZD as antidiabetic drugs being correlated to their potency as PPAR agonists in vitro (15). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Convincing evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that"

Phrase: "the transcription factor peroxisomal proliferator-activated receptor- (PPAR)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   883   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   883   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the intracellular receptor for TZD action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0166417:Thiazolidinedione Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "with the in vivo efficacy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1280519:Efficacy [Qualitative Concept]
   827   C1707887:EFFICACY [Research Activity]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "of TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "as antidiabetic drugs"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0935929:Antidiabetic Drugs [Pharmacologic Substance]
           antidiabetic
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "being"

Phrase: "correlated to their potency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "as PPAR agonists"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0243192:agonists [Pharmacologic Substance]
   804   C2987634:agonists [Pharmacologic Substance]
   753   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.30: In this model, the insulin sensitization would involve transcriptional regulation and enhanced expression of genes representing critical components of the insulin signaling cascade (1, 2). 

Phrase: "In this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "the insulin sensitization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1325847:Sensitisation [Mental Process]

Phrase: "would"

Phrase: "involve"

Phrase: "transcriptional regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158770:Transcriptional Regulation [Genetic Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "enhanced expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "critical components of the insulin signaling cascade"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0449432:Components [Manufactured Object]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.31: Consistently, most TZD require long term treatment, and a number of fat cell-specific genes and additionally GLUT4 (8) have been shown to be controlled by these drugs (16) in agreement with high expression of PPAR in this tissue (17). 

Phrase: "Consistently,"

Phrase: "most TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "require"

Phrase: "long term treatment,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023977:long-term treatment [Health Care Activity]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0443252:Long-term [Temporal Concept]

Phrase: "and"

Phrase: "a number of fat cell-specific genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "additionally GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420175:GLUT4 [Gene or Genome]
   861   C2982484:GLUT4 [Gene or Genome]

Phrase: "(8"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "controlled by these drugs"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   833   C0332298:Controlled by [Functional Concept]
   819   C0360835:controlled drugs [Regulation or Law]
   802 E C0013168:control drugs [Governmental or Regulatory Activity]
   770   C0013227:Drugs [Pharmacologic Substance]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1254351:Drug [Pharmacologic Substance]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with high expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of PPAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   982   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   982   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "in this tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.32: However, TZD-responsive genes of the insulin signaling cascade have not been identified to date. 

Phrase: "However,"

Phrase: "TZD-responsive genes of the insulin signaling cascade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1337112:Insulin Gene [Gene or Genome]
   744   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "identified to date."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0011008:Date [Temporal Concept]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C2348077:Date [Food]
Processing 00000000.tx.33: 2) We (9) and others (18) have shown that TZD may be able to modulate protein kinase C (PKC) activity in muscle tissue. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "We (9"

Phrase: ")"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(18"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "protein kinase C (PKC) activity in muscle tissue."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   853   C1150572:protein kinase C activity [Molecular Function]
   804   C1150527:protein kinase activity [Molecular Function]
   804   C3642159:Protein C Activity [Laboratory Procedure]
   786 E C2261495:protein phosphokinase activity [Molecular Function]
   774   C1150423:kinase activity [Molecular Function]
   774   C1537044:protein activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   738   C0231484:Muscular activity [Organ or Tissue Function]
Processing 00000000.tx.34: This involves acute inhibition of membrane-associated PKC isoforms (9) as well as reversal of chronic alterations of PKC in fat-fed rats (18, 19). 

Phrase: "This"

Phrase: "involves"

Phrase: "acute inhibition of membrane-associated PKC isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "(9"

Phrase: ")"

Phrase: "as well as"

Phrase: "reversal of chronic alterations of PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443290:Reversal [Functional Concept]

Phrase: "in fat-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.35: As serine phosphorylation of early signaling components may play a pivotal role in the pathogenesis of insulin resistance (20), modulation of PKC by TZD may represent an additional, yet less defined, pathway for the action of these compounds. 

Phrase: "As serine phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "of early signaling components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a pivotal role in the pathogenesis of insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "modulation of PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "by TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an additional, yet less"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1524062:Additional [Functional Concept]
   755 E C1883712:Addition [Functional Concept]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: ","

Phrase: "pathway for the action of these compounds."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.36: 3) More recent studies by Berger and co-workers (21, 22) suggest that pioglitazone and several other TZD may be able to directly potentiate insulin signaling at the level of phosphatidylinositol (PI) 3-kinase in Chinese hamster ovary cells overexpressing human insulin receptors and in adipose tissue. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "More recent studies by Berger"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(21,"

Phrase: "22"

Phrase: ")"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that pioglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071097:pioglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "able to directly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1947931:Directly [Qualitative Concept]

Phrase: "potentiate"

Phrase: "insulin signaling at the level of phosphatidylinositol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037083:Signaling [Cell Function]
   748   C3537152:signaling [Biologic Function]

Phrase: "(PI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: ")"

Phrase: "3-kinase in Chinese hamster ovary cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "human insulin receptors"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   966   C1448132:insulin receptor, human [Amino Acid, Peptide, or Protein,Receptor]
   901   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   867 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and in adipose tissue."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0001527:Adipose tissue [Tissue]
   770   C0040300:Tissue [Tissue]
   770   C1515981:And [Idea or Concept]
   770   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.37: However, these findings were not confirmed in 3T3-L1 adipocytes (23). 

Phrase: "However,"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confirmed in 3T3-L1 adipocytes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0206131:Adipocytes [Cell]
   760   C0441918:L1 [Finding]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.38: Further, the precise mechanism underlying PI 3-kinase modulation by TZD remains obscure. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the precise mechanism underlying PI 3-kinase modulation by TZD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0443264:Modulation [Spatial Concept]

Phrase: "remains"

Phrase: "obscure."
Processing 00000000.tx.39: Using isolated rat cardiomyocytes, we have now characterized the action profile of a novel TZD drug, MCC-555 (Fig. 1). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "isolated rat cardiomyocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0225828:Cardiomyocytes [Cell]

Phrase: "we"

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the action profile of a novel TZD drug,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1979963:Profile [Laboratory Procedure]
   744   C2003903:Profile [Functional Concept]

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.40: In insulin-resistant rodent models, this compound was shown to be 5 times more potent than pioglitazone (24). 

Phrase: "In insulin-resistant rodent models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Models [Intellectual Product]

Phrase: "this compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "5 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "more potent than pioglitazone"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.41: We therefore investigated whether MCC-555 was able to modify insulin signaling in a primary muscle cell and if this might serve to ameliorate insulin resistance in myocytes from obese Zucker rats (20). 

Phrase: "We therefore"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "insulin signaling in a primary muscle cell"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0037083:Cell Signaling [Cell Function]
           Signaling
   748   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "if"

Phrase: "this"

Phrase: "might"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ameliorate"

Phrase: "insulin resistance in myocytes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from obese Zucker rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.42: The data show that MCC-555 acutely sensitizes insulin action by increasing the intrinsic activity of insulin receptor substrate-1 (IRS-1)-associated PI 3-kinase activity. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that MCC-555 acutely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "sensitizes"

Phrase: "insulin action by increasing"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0020459:increasing insulin [Disease or Syndrome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0441472:Action [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3266814:Action [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "the intrinsic activity of insulin receptor substrate-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C1150623:insulin receptor activity [Molecular Function]
   767   C1145751:insulin activity [Molecular Function]
   767   C1152633:receptor activity [Molecular Function]
   744   C0205102:Intrinsic [Spatial Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0439674:Intrinsic [Functional Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "(IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")-"

Phrase: "associated PI 3-kinase activity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   888   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.43: The drug effect was dependent on protein synthesis and may involve the PPAR pathway. 

Phrase: "The drug effect"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0728866:Drug effect [Functional Concept]
  1000   C0728867:Drug effect [Pathologic Function]
  1000   C1411996:drug effect [Biologic Function]
   861   C0013227:Drug [Pharmacologic Substance]
   861   C1254351:Drug [Pharmacologic Substance]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "was"

Phrase: "dependent on protein synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "involve"

Phrase: "the PPAR pathway."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   753   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
Processing 00000000.tx.44: View larger version (8K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(8K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.45: Structure of MCC-555.   

Phrase: "Structure of MCC-555."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.46: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Chemicals 3-O-[Methyl-14C]D-glucose ([methyl-14C]3-OMG; SA, 57 Ci/mmol), L-[1-14C]glucose (SA, 58 Ci/mmol), [33P]orthophosphate (SA, 3000 Ci/mmol), and 125I-labeled protein A (30 mCi/mg) were obtained from Amersham (Braunschweig, Germany). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Chemicals 3-O-[Methyl-14C"

Phrase: "]"

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: "[methyl-14C"

Phrase: "]3-OMG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417949:OMG [Gene or Genome]

Phrase: "; SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "57 Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "L-[1-14C"

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "58 Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "[33P"

Phrase: "]orthophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "(SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "3000 Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "125I-labeled protein A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(30 mCi/mg)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C2348019:mCi/mg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Amersham"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Braunschweig,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.47: [-32P]ATP (SA, 6000 Ci/mmol) was purchased from New England Nuclear (Dreieich, Germany). 

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "(SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "6000 Ci/mmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "was"

Phrase: "purchased from New England"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0027965:New England [Geographic Area]
   770   C0014282:England [Geographic Area]
   770   C0205314:New [Temporal Concept]
   770   C0869011:purchased [Activity]

Phrase: "Nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "(Dreieich,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.48: Collagenase was a product of Serva (Heidelberg, Germany). 

Phrase: "Collagenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "was"

Phrase: "a product of Serva"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514468:product [Entity]
   770   C1704444:Product [Quantitative Concept]

Phrase: "(Heidelberg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.49: Wortmannin, cycloheximide, and PI were supplied by Sigma Chemical Co. 

Phrase: "Wortmannin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "cycloheximide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "PI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: "were"

Phrase: "supplied by Sigma Chemical Co."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0220806:Chemical [Chemical]
   760   C1719918:Sigma [Intellectual Product]
   760   C1999230:Supplied [Activity]
   760   C3272558:Chemical [Intellectual Product]
   726 E C0243163:supply [Idea or Concept]
   726 E C0699914:supply [Quantitative Concept]
   726 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   726 E C1561604:supply [Functional Concept]
   726 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.50: (Munich, Germany). 

Phrase: "(Munich,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.51: Polyclonal anti-p85 antibodies as well as the monoclonal antiphosphotyrosine antibody coupled to alkaline phosphatase were obtained from Upstate Biotechnology, Inc. 

Phrase: "Polyclonal anti-p85 antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   886   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "the monoclonal antiphosphotyrosine antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "coupled to alkaline phosphatase"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1149880:phosphatase [Molecular Function]
   770   C1948027:Coupled [Functional Concept]
   770   C1979842:Alkaline [Qualitative Concept]
   737 E C0010222:couple [Family Group]

Phrase: "were"

Phrase: "obtained from Upstate Biotechnology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "Inc."
Processing 00000000.tx.52: (Lake Placid, NY). 

Phrase: "(Lake Placid, NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.53: The anti-IRS-1 antibody was provided by Dr. 

Phrase: "The anti-IRS-1 antibody"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   919   C0443876:Anti-insulin receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Insulin receptor antibody
   904   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "was"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.54: Ton Maassen (Leiden, The Netherlands). 

Phrase: "Ton Maassen"

Phrase: "(Leiden,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")."
Processing 00000000.tx.55: The antiinsulin receptor antibody was obtained from Transduction Laboratories (Lexington, MA). 

Phrase: "The antiinsulin receptor antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0443876:Anti-insulin receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C0021644:Anti-insulin antibody [Immunologic Factor]
   901   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "obtained from Transduction Laboratories"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C1160185:transduction [Organism Function]
   770   C1301820:Obtained [Functional Concept]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C1706701:Obtain [Activity]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "(Lexington,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.56: Polyclonal PPAR antiserum was provided by J. 

Phrase: "Polyclonal PPAR antiserum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   716   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "was"

Phrase: "provided by J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.57: Holder (Epsom, UK). 

Phrase: "Holder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551377:holder [Manufactured Object]
  1000   C1555310:Holder [Idea or Concept]
  1000   C1706054:Holder [Medical Device]

Phrase: "(Epsom,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.58: Protein A- and protein G beads were supplied by Pierce Chemical Co. 

Phrase: "Protein A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "protein G beads"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]
   734   C0060916:protein g [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "supplied by Pierce Chemical Co."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0220806:Chemical [Chemical]
   760   C1999230:Supplied [Activity]
   760   C3272558:Chemical [Intellectual Product]
   726 E C0243163:supply [Idea or Concept]
   726 E C0699914:supply [Quantitative Concept]
   726 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   726 E C1561604:supply [Functional Concept]
   726 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.59: (Cologne, Germany). 

Phrase: "(Cologne,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0678428:cologne [Substance]
  1000   C2709265:Cologne [Fish]

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.60: MCC-555 was provided by Mitsubishi Chemical Co. 

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "provided by Mitsubishi Chemical Co."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220806:Chemical [Chemical]
   760   C1999230:Provided [Activity]
   760   C3272558:Chemical [Intellectual Product]
Processing 00000000.tx.61: (Yokohama, Japan). 

Phrase: "(Yokohama,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.62: All other chemicals were of the highest analytical grade and were purchased from Sigma Chemical Co. or Merck (Darmstadt, Germany). 

Phrase: "All"

Phrase: "other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were of the highest analytical grade"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   767   C0205082:High grade [Qualitative Concept]
   753   C0441800:Grade [Classification]
   753   C0919553:Grade [Classification]
   753   C0936012:Analytical [Research Activity]
   753   C1522410:Highest [Qualitative Concept]
   753   C3244287:grade [Finding]
   719 E C0205250:High [Qualitative Concept]
   719 E C1299351:High [Qualitative Concept]
   719 E C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "were"

Phrase: "purchased from Sigma Chemical Co."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0220806:Chemical [Chemical]
   760   C0869011:purchased [Activity]
   760   C1719918:Sigma [Intellectual Product]
   760   C3272558:Chemical [Intellectual Product]

Phrase: "or"

Phrase: "Merck"

Phrase: "(Darmstadt,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.63: Isolation of ventricular cardiomyocytes Ca2+-tolerant myocytes were isolated from male Wistar rats (260320 g) or genetically obese (fa/fa) male Zucker rats (480520 g) by perfusion of the heart with collagenase as previously described by us (25, 26). 

Phrase: "Isolation of ventricular cardiomyocytes Ca2+-tolerant myocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0204727:Isolation [Therapeutic or Preventive Procedure]
   748   C0205409:Isolation [Functional Concept]
   748   C0220862:isolation [Laboratory Procedure]

Phrase: "were"

Phrase: "isolated from male Wistar rats"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0034716:Rats, Wistar [Mammal]
   760   C0024554:Male [Finding]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0086582:male [Population Group]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1706180:Male [Qualitative Concept]
   760   C1706428:Male [Qualitative Concept]
   760   C1706429:Male [Organism Attribute]
   760   C2700262:Wistar [Mammal]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(260320 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "genetically obese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028754:Obese [Disease or Syndrome]

Phrase: "(fa/fa) male Zucker rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0034719:Rats, Zucker [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
   804   C2700303:Zucker [Mammal]

Phrase: "(480520 g) by perfusion of the heart"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]

Phrase: "with collagenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described by us (25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.64: All animal experimentation was performed according to approved protocols. 

Phrase: "All animal experimentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003048:Animal Experimentation [Research Activity]
   861   C0678323:experimentation [Research Activity]

Phrase: "was"

Phrase: "performed according to approved protocols."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C2346846:Approved Protocol [Functional Concept]
   760   C0205540:Approved [Qualitative Concept]
   760   C0442711:Protocols [Intellectual Product]
   760   C0680240:according [Social Behavior]
   760   C0884358:Performed [Functional Concept]
   726 E C1507394:Protocol [Intellectual Product]
   726 E C1522729:Protocol [Intellectual Product]
   726 E C2348563:Protocol [Intellectual Product]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.65: The final cell suspension was washed three times with HEPES buffer (130 mM NaCl, 4.8 mM KCl, 1.2 mM KH2PO4, 25 mM HEPES, 5 mM glucose, and 20 g/liter BSA, pH 7.4, equilibrated with oxygen) and incubated in silicone-treated Erlenmeyer flasks in a rotating water bath shaker at 37 C. 

Phrase: "The final cell suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038960:Suspension [Biomedical or Dental Material]
   827   C1382107:Suspension [Substance]
   827   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with HEPES buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "(130 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "4.8 mM KCl,"

Phrase: "1.2 mM KH2PO4,"

Phrase: "25 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "5 mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "20 g/liter BSA,"

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "equilibrated with oxygen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "incubated in silicone-treated Erlenmeyer flasks"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0037114:Silicone [Biomedical or Dental Material,Organic Chemical]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C0872171:flasks [Medical Device]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "in a rotating water bath shaker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0687735:Shaker [Population Group]

Phrase: "at 37 C."
Processing 00000000.tx.66: After 20 min, CaCl2 and MgSO4 (final concentration, 1 mM) were added, and incubation was continued for at least 60 min. 

Phrase: "After 20 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "CaCl2"

Phrase: "and"

Phrase: "MgSO4"

Phrase: "(final concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "1 mM)"

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "incubation"

Phrase: "was"

Phrase: "continued for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0549178:Continued [Idea or Concept]

Phrase: "at least 60 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.67: Cell viability was checked by determination of the percentage of rod-shaped cells and averaged 9095% under all incubation conditions. 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "checked by determination of the percentage of rod-shaped cells"
Meta Candidates (Total=22; Excluded=4; Pruned=0; Remaining=18)
   757   C0162657:cells shaped [Organism Attribute]
   757   C0206427:cells rod [Cell]
           Rod
   743   C1947942:Rod Shape [Spatial Concept]
           Rod
   739   C0007634:Cells [Cell]
   739   C0332479:shaped [Spatial Concept]
   739   C0439165:Percentage [Quantitative Concept]
   739   C0522512:shaped [Spatial Concept]
   739   C1148554:determination [Laboratory Procedure]
   739   C1283174:Checked [Activity]
   739   C1549488:Percentage [Idea or Concept]
   739   C1552915:rod [Quantitative Concept]
   739   C1561533:Percentage [Idea or Concept]
   739   C1705186:Rod [Medical Device]
   739   C2347970:rod [Quantitative Concept]
   739   C2347971:rod [Quantitative Concept]
   739   C3282337:Cells [Cell]
   706 E C0348078:shape [Qualitative Concept]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "9095% under all incubation conditions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.68: For labeling with [33P]orthophosphate, freshly prepared cardiomyocytes were incubated in phosphate-free HEPES buffer with 100 Ci [33P]orthophosphate/ml cell suspension (1 x 106 cells/ml) for 2.5 h, as recently described (20). 

Phrase: "For labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[33P"

Phrase: "]orthophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "freshly prepared cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0225828:Cardiomyocytes [Cell]

Phrase: "were"

Phrase: "incubated in phosphate-free HEPES buffer"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0332296:free [Functional Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]

Phrase: "with 100 Ci [33P"

Phrase: "]orthophosphate/ml cell suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0038960:Suspension [Biomedical or Dental Material]
   812   C1382107:Suspension [Substance]
   812   C1705537:Suspension [Functional Concept]

Phrase: "(1 x 106 cells/ml) for 2.5 h,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C2699156:Cells/mL [Quantitative Concept]
   762   C0439391:mL/h [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]

Phrase: "as"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.69: Assay of 3-OMG transport Transport experiments were performed at 37 C in HEPES buffer containing MgCl2 (1 mM) and CaCl2 (1 mM). 

Phrase: "Assay of 3-OMG transport Transport experiments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed at 37 C in HEPES buffer containing MgCl2"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]
   742   C0332256:Containing [Functional Concept]
   742   C0884358:Performed [Functional Concept]
   742   C2700400:Containing [Activity]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(1 mM)"

Phrase: "and"

Phrase: "CaCl2"

Phrase: "(1 mM"

Phrase: ")."
Processing 00000000.tx.70: The reaction was started by pipetting a 50-l aliquot of the cell suspension to 50 l HEPES buffer containing [methyl-14C]3-OMG (final concentration, 100 M). 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "started by pipetting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1272689:Started [Qualitative Concept]
   756   C0182301:Pipette [Medical Device]
   756 E C0439659:Start [Temporal Concept]
   756   C1706407:Pipette [Medical Device]

Phrase: "a 50-l aliquot of the cell suspension"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1510844:Aliquot [Quantitative Concept]

Phrase: "to 50 l HEPES buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "[methyl-14C"

Phrase: "]3-OMG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417949:OMG [Gene or Genome]

Phrase: "(final concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "100"

Phrase: "M)."
Processing 00000000.tx.71: Carrier-mediated glucose transport was then determined using a 10-sec assay period and L-[14C]glucose to correct for simple diffusion as described in earlier reports from this laboratory (9, 20). 

Phrase: "Carrier-mediated glucose transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0700215:carrier mediated transport [Cell Function]
   861   C0178666:glucose transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 10-sec assay period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0439531:/period [Temporal Concept]
   804   C1948053:Period [Temporal Concept]
   733 E C0332182:Periodic [Temporal Concept]
   733 E C1706381:PERIODIC [Intellectual Product]
   704 E C0031084:Periodicities [Temporal Concept]

Phrase: "and"

Phrase: "L-[14C"

Phrase: "]glucose to correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "for simple diffusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012222:Diffusion [Natural Phenomenon or Process]
   861   C1696141:Diffusion [Functional Concept]

Phrase: "as"

Phrase: "described in earlier reports"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   770   C1552738:described [Idea or Concept]
   737   C1279919:Early [Temporal Concept]
   737 E C3273238:Report [Intellectual Product]

Phrase: "from this laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "(9,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.72: Immunoprecipitation Cells were treated with different doses of MCC-555, stimulated with insulin as indicated, and lysed in a buffer containing 50 mM Tris, 150 mM NaCl, 20 mM NaF, 10 mM EDTA, 1 mM Na3VO4, 0.3 mM phenylmethylsulfonylfluoride, 2 M leupeptin, 2 M pepstatin, 4 trypsin inhibitor units/ml aprotinin, and 1% (vol/vol) Triton, pH 7.4. 

Phrase: "Immunoprecipitation Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with different doses of MCC-555,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   748   C0178602:Doses [Quantitative Concept]
   748   C1522326:Treated [Functional Concept]
   748   C1705242:Different [Qualitative Concept]
   714 E C0869039:Dose [Quantitative Concept]
   714 E C1114758:Dose # [Clinical Attribute]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1428722:DOS [Gene or Genome]

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "and"

Phrase: "lysed in a buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:lysed [Pathologic Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "20 mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "10 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM Na3VO4,"

Phrase: "0.3 mM phenylmethylsulfonylfluoride,"

Phrase: "2 M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "2 M pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "4 trypsin inhibitor units/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(vol/vol) Triton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242759:Triton [Geographic Area]

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.73: After incubation for 1 h, the suspension was centrifuged at 16,000 x g for 5 min. 

Phrase: "After incubation"

Phrase: "for 1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038960:Suspension [Biomedical or Dental Material]
  1000   C1382107:Suspension [Substance]
  1000   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "centrifuged at 16,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.74: After this, the supernatant was subjected to immunoprecipitation. 

Phrase: "After this,"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "subjected to immunoprecipitation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]
Processing 00000000.tx.75: For immunoprecipitation of IRS-1, the antiserum was preadsorbed to protein A/protein G beads for 2 h at 4 C, then added to the solubilized cell supernatant and incubated for 16 h at 4 C with gentle rotation. 

Phrase: "For immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "of IRS-1,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "preadsorbed to protein A/protein G"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C0060916:protein g [Amino Acid, Peptide, or Protein]
   783   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439267:g% [Quantitative Concept]

Phrase: "beads for 2 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0991566:Beads [Biomedical or Dental Material]
   770   C2346972:Bead [Spatial Concept]

Phrase: "at 4 C,"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to the solubilized cell supernatant"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0007634:Cell [Cell]
   753   C1269647:Cell [Cell]
   753   C1524062:Added [Functional Concept]
   753   C1550101:Supernatant [Body Substance]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated for 16 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4 C"

Phrase: "with gentle rotation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0035868:Rotation [Functional Concept]
   861   C0677597:Rotation [Functional Concept]
   789 E C0445237:Rotational [Spatial Concept]
Processing 00000000.tx.76: After centrifugation, the immunopellet was washed three times with lysis buffer and twice with PBS. 

Phrase: "After centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "the immunopellet"

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with lysis buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "twice with PBS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.77: Immunoprecipitation of the insulin receptor was performed using 5 g of the monoclonal insulin receptor antibody 29B4, as detailed previously (27). 

Phrase: "Immunoprecipitation of the insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "5 g of the monoclonal insulin receptor antibody 29B4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0439267:g% [Quantitative Concept]

Phrase: "as"

Phrase: "detailed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "previously"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.78: Immunoblotting For phosphotyrosine detection the immunoprecipitates were separated by SDS-PAGE using gradient (818%) horizontal gels and transferred to polyvinylidene difluoride filters in a semidry blotting apparatus (28). 

Phrase: "Immunoblotting For phosphotyrosine detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "the immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "(818%"

Phrase: ")"

Phrase: "horizontal gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transferred to polyvinylidene difluoride filters"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0180860:Filters [Manufactured Object]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C0581406:Filter [Medical Device]
   726 E C1522664:Filter [Intellectual Product]
   726 E C1704449:Filter [Conceptual Entity]
   726 E C1704684:Filter [Medical Device]
   726 E C1705822:Transfer [Activity]
   726 E C1875155:FILTER [Medical Device]

Phrase: "in a semidry blotting apparatus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243111:apparatus [Manufactured Object]
   827   C1947951:Apparatus [Anatomical Structure]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.79: Filters were blocked for 60 min in PBS, pH 7.4, containing 1% BSA. 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "blocked for 60 min"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% BSA."
Processing 00000000.tx.80: Thereafter, filters were incubated for 16 h at 4 C with a 1:1000 dilution of the antiphosphotyrosine antibody conjugated to alkaline phosphatase. 

Phrase: "Thereafter,"

Phrase: "filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "incubated for 16 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4 C"

Phrase: "with a 1"

Phrase: ":"

Phrase: "1000 dilution of the antiphosphotyrosine antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1948037:Dilution [Functional Concept]

Phrase: "conjugated to alkaline phosphatase."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0522529:Conjugated [Spatial Concept]
   770   C1149880:phosphatase [Molecular Function]
   770   C1979842:Alkaline [Qualitative Concept]
   737 E C0301869:Conjugate [Immunologic Factor]
Processing 00000000.tx.81: Substrates for alkaline phosphatase were then added for appropriate color development. 

Phrase: "Substrates for alkaline phosphatase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added for appropriate color development."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0009393:Color [Natural Phenomenon or Process]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1524062:Added [Functional Concept]
   760   C1527148:Development [Functional Concept]
   760   C1548787:Appropriate [Qualitative Concept]
   760   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   760   C1705245:Color [Pharmacologic Substance]
   726 E C1883712:Add [Functional Concept]
Processing 00000000.tx.82: For detection of the p85 regulatory subunit of PI 3-kinase, the blots were incubated overnight with the p85 antiserum at a 1:1000 dilution. 

Phrase: "For detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of the p85 regulatory subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "of PI 3-kinase,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the blots"

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight with the p85 antiserum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0439583:Overnight [Temporal Concept]
   760   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C3541313:p85 [Gene or Genome]

Phrase: "at a 1"

Phrase: ":"

Phrase: "1000 dilution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.83: After extensive washing, filters were incubated for 2 h with [125I]protein A, washed, air-dried, and visualized on a Fujix BAS 1000 bioimaging analyzer (Fuji Photo Film Co., Ltd., Tokyo, Japan). 

Phrase: "After extensive washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Washing [Activity]

Phrase: "filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with"

Phrase: "[125I"

Phrase: "]protein A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "air-dried"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0001861:Air [Substance]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ","

Phrase: "and"

Phrase: "visualized on a Fujix BAS 1000 bioimaging analyzer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0179038:Analyzer [Medical Device]
   744   C0234621:Visualized [Functional Concept]
   744   C0872020:bioimaging [Intellectual Product]
   744   C1706246:Analyzer [Manufactured Object]
   744   C1862288:BAS [Clinical Attribute]

Phrase: "(Fuji Photo Film Co.,"

Phrase: "Ltd.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1136140:LTD [Organ or Tissue Function]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.84: Quantification was performed densitometrically using BioImage whole band analysis software (Millipore Corp., Eschborn, Germany). 

Phrase: "Quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "densitometrically"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BioImage whole band analysis software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Millipore Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "Eschborn,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.85: Immunoblotting of PPAR was performed using whole cell extracts (lysis buffer: 10 mM Tris, 5 mM EGTA, 0.1 mM dithiothreitol, 2 mM phenylmethylsulfonylfluoride, 0.12 g/ml leupeptin, and 0.5% SDS) from cardiomyocytes and human adipocytes (27). 

Phrase: "Immunoblotting of PPAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "whole cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "(lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ":"

Phrase: "10 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "5 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "2 mM phenylmethylsulfonylfluoride,"

Phrase: "0.12 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.5% SDS) from cardiomyocytes"

Phrase: "and"

Phrase: "human adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206131:Adipocytes [Cell]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.86: Blots were incubated with the PPAR antiserum at a 1:2000 dilution as described above and processed for enhanced chemiluminescence detection using a horseradish peroxidase-conjugated goat antirabbit antibody. 

Phrase: "Blots"

Phrase: "were"

Phrase: "incubated with the PPAR antiserum"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   815   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   815   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   744   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1879547:Activated [Activity]
   744   C3546463:peroxisomal [Cell Component]
   735   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   711 E C1515877:Activate [Functional Concept]

Phrase: "at a 1"

Phrase: ":"

Phrase: "2000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "and"

Phrase: "processed for enhanced chemiluminescence detection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   760   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   760   C1522240:Processed [Phenomenon or Process]
   760   C2349975:Enhanced [Activity]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a horseradish peroxidase-conjugated goat antirabbit antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.87: Assay of PI 3-kinase activity PI 3-kinase activity was measured directly in IRS-1 immunoprecipitates in 50 l of a reaction mixture containing 0.2 mg/ml PI, 20 mM HEPES (pH 7.1), 0.4 mM EGTA, 0.4 mM Na2HPO4, and 10 mM MgCl2 in the absence or presence of wortmannin (1 M). 

Phrase: "Assay of PI 3-kinase activity PI 3-kinase activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0005507:Assay [Laboratory Procedure]
   739   C0243073:assay [Qualitative Concept]
   739   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "directly in IRS-1 immunoprecipitates"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   778   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   778   C1334133:INSULIN RECEPTOR [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1710236:Substrate [Manufactured Object]
   748   C1947931:Directly [Qualitative Concept]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "in 50 l"

Phrase: "of a reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.2 mg/ml PI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   804   C2348046:Phosphatidylinositol [Lipid]

Phrase: "20 mM HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "0.4 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.4 mM Na2HPO4,"

Phrase: "and"

Phrase: "10 mM MgCl2 in the absence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "presence of wortmannin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M)."
Processing 00000000.tx.88: The latter completely blocks PI 3-kinase activity and was used for the determination of background activity. 

Phrase: "The latter completely"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "PI 3-kinase activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   923   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "was"

Phrase: "used for the determination of background activity."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   757   C1524063:Use of [Functional Concept]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1148554:determination [Laboratory Procedure]
   748   C1273517:used [Finding]
   748   C1561536:*Activity [Idea or Concept]
   748   C1706907:Background [Conceptual Entity]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.89: The kinase buffer was incubated with the immunoprecipitates for 5 min at room temperature, and the reaction was started by addition of [-32P]ATP (40 M and 0.1 Ci/l). 

Phrase: "The kinase buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "incubated with the immunoprecipitates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1439852:Incubated [Laboratory Procedure]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "started by addition of [-32P"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C1272689:Started [Qualitative Concept]
   760   C1553631:32p [Medical Device]
   760   C1883712:Addition [Functional Concept]
   726 E C0439659:Start [Temporal Concept]

Phrase: "]ATP"

Phrase: "(40 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "0.1 Ci/"

Phrase: "l)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.90: After 20 min, the reaction was stopped by the addition of 30 l 4 N HCl and 130 l chloroform-methanol (1:1). 

Phrase: "After 20 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by the addition of 30 l 4 N HCl"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   739   C1272691:stopped [Qualitative Concept]
   739   C1883712:Addition [Functional Concept]
   706 E C1947925:Stop [Activity]
   706 E C2746065:Stop [Temporal Concept]

Phrase: "and"

Phrase: "130 l chloroform-methanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   812   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.91: The organic phase was extracted and spotted on a silica gel TLC plate (Merck) and developed in chloroform-methanol-25% NH4OH-water (43:38:5:7, vol/vol/vol/vol). 

Phrase: "The organic phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "spotted on a silica gel TLC plate"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C2936385:Silica Gel [Biomedical or Dental Material,Inorganic Chemical]
   748   C0005971:Plate [Medical Device]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0037098:Silica [Biomedical or Dental Material,Inorganic Chemical]
   748   C1139930:plate [Medical Device]
   748   C1382104:Gel [Substance]
   748   C3537155:Plate [Manufactured Object]
   714   C0329155:Spot [Fish]
   714   C1427618:SPOT [Gene or Genome]
   714   C1705203:Spot [Conceptual Entity]

Phrase: "(Merck"

Phrase: ")"

Phrase: "and"

Phrase: "developed in chloroform-methanol-25% NH4OH-water"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   748   C0599638:WATER [Substance]
   748   C1550678:Water [Inorganic Chemical]

Phrase: "(43"

Phrase: ":"

Phrase: "38"

Phrase: ":"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "7,"

Phrase: "vol/vol/vol/vol)."
Processing 00000000.tx.92: Plates were dried and subsequently visualized and analyzed on a Fujix BAS 1000 bioimaging analyzer. 

Phrase: "Plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "subsequently"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "and"

Phrase: "analyzed on a Fujix BAS 1000 bioimaging analyzer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0179038:Analyzer [Medical Device]
   744   C0872020:bioimaging [Intellectual Product]
   744   C0936012:Analyzed [Research Activity]
   744   C1706246:Analyzer [Manufactured Object]
   744   C1862288:BAS [Clinical Attribute]
Processing 00000000.tx.93: Presentation of data and statistics All data analysis was performed using Prism (GraphPad, San Diego, CA) or t-ease (ISI, Philadelphia, PA) statistical software. 

Phrase: "Presentation of data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449450:Presentation [Idea or Concept]

Phrase: "and"

Phrase: "statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]

Phrase: "All data analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Prism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0814195:PRISM [Intellectual Product]
   944 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(GraphPad,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "or"

Phrase: "t-ease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1331418:Ease [Mental Process]
   789 E C0332219:Easy [Qualitative Concept]

Phrase: "(ISI,"

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA) statistical software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.94: The significance of reported differences was evaluated using the null hypothesis and t statistics for paired data. 

Phrase: "The significance of reported differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the null hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456148:Null [Quantitative Concept]
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "and"

Phrase: "t statistics for paired data."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C2828391:Statistic (data) [Quantitative Concept]
       E   Statistic
   760   C0038215:Statistics [Occupation or Discipline]
   760   C0600673:Statistics [Intellectual Product]
   726 E C2348149:Statistic [Quantitative Concept]
Processing 00000000.tx.95: Corresponding significance levels are indicated in the figures.  

Phrase: "Corresponding significance levels"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   867   C0814896:Significance Level [Research Activity]
   827   C0237881:Significance [Quantitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C0750502:Significance [Idea or Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C1546944:Significant [Qualitative Concept]

Phrase: "are"

Phrase: "indicated in the figures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.96: Results Top Abstract Introduction Materials and Methods Results Discussion References  Effects of MCC-555 on glucose transport To gain initial insights into the action profile of MCC-555 in cardiomyocytes, we preincubated the cells with two different concentrations of the drug (10 and 100 M, respectively) for 30 min followed by determination of the initial influx (10 sec) of 3-OMG, representing carrier-mediated transport. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Effects of MCC-555"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on glucose transport To"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0178666:glucose transport [Cell Function]
   901   C1550030:Transport To [Idea or Concept]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "initial insights into the action profile of MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0233820:insights [Mental Process]

Phrase: "in cardiomyocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "we"

Phrase: "preincubated"

Phrase: "the cells with two different concentrations of the drug"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0007634:THE CELL [Cell]
           Cells
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(10"

Phrase: "and"

Phrase: "100 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "respectively"

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by determination of the initial influx"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0205265:Initial [Temporal Concept]
   748   C1148554:determination [Laboratory Procedure]
   748   C1279901:Initial [Qualitative Concept]
   748   C1555582:Initial [Idea or Concept]
   748   C1705685:INITIAL [Functional Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "(10 sec) of 3-OMG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   835   C3541894:10^3 sec [Quantitative Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "carrier-mediated transport."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0700215:carrier mediated transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]
Processing 00000000.tx.97: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.98: 2 (upper panel, left), MCC-555 did not modify basal glucose transport, suggesting that this compound does not elicit insulin-like signals in an acute fashion. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(upper panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "basal glucose transport,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "insulin-like signals in an acute fashion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.99: On the other hand, the stimulatory action of insulin on glucose transport was markedly enhanced in the presence of high concentrations of MCC-555. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the stimulatory action of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "on glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "enhanced in the presence of high concentrations of MCC-555."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   739   C0086045:Concentrations [Mental Process]
   739   C0205250:High [Qualitative Concept]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1299351:High [Qualitative Concept]
   739   C2349975:Enhanced [Activity]
   739   C2700149:HIGH [Intellectual Product]
   706 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.100: Thus, the incremental increase in glucose transport due to insulin at physiological concentrations of the hormone (3 x 10-11 M) was enhanced about 3-fold from 169 to 476 pmol 3-OMG/106 cells10 sec (Fig. 2, upper panel, right). 

Phrase: "Thus,"

Phrase: "the incremental increase in glucose transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "due to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "at physiological concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of the hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormone [Hormone]
   928 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(3 x 10-11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: "M)"

Phrase: "was"

Phrase: "enhanced about 3-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332462:Fold [Spatial Concept]
   770   C1880834:FOLD [Phenomenon or Process]
   770   C2349975:Enhanced [Activity]

Phrase: "from 169"

Phrase: "to 476 pmol 3-OMG/106 cells10 sec (Fig. 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C0349966:Fig [Food]
   791   C0439192:pmol [Quantitative Concept]
   791   C1337208:FIG [Food]
   791   C1417949:OMG [Gene or Genome]

Phrase: "upper panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.101: A significant, but less pronounced, effect was also detected for the maximum insulin response (increase of 1.7-fold over the control value). 

Phrase: "A significant,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "but"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "pronounced"

Phrase: ","

Phrase: "effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "detected for the maximum insulin response"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0442726:Detected [Finding]
   753   C0806909:Maximum [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1552615:maximum [Quantitative Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2826546:MAXIMUM [Quantitative Concept]
   753   C2911692:Response [Mental Process]

Phrase: "(increase of 1.7-fold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "over the control value"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0243148:control [Qualitative Concept]
   861   C1522609:Value [Quantitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.102: This acute response of MCC-555 was only detected at a 100-M concentration of the drug. 

Phrase: "This acute response of MCC-555"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "detected at a 100-M concentration of the drug."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   762   C0678756:drug concentration [Quantitative Concept]
   742   C0013227:Drug [Pharmacologic Substance]
   742   C0086045:Concentration [Mental Process]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
   742   C0442726:Detected [Finding]
   742   C1254351:Drug [Pharmacologic Substance]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.103: We therefore extended the incubation periods using a 2-h protocol and analyzed the effects of 10 M MCC-555 on glucose transport in the absence and presence of physiological concentrations of insulin (Fig. 2, lower panel, left). 

Phrase: "We therefore"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "the incubation periods"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1320226:incubation periods [Finding]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 2-h protocol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the effects of 10 M MCC-555"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "presence of physiological concentrations of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.104: Again, no significant effect of the drug on basal glucose uptake was detected, supporting our above-mentioned conclusions. 

Phrase: "Again,"

Phrase: "no significant effect of the drug"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0542119:NO DRUG EFFECT [Finding]
   793   C0728866:effect of drugs [Functional Concept]
           Drug effect
   783   C0728867:Drug effect [Pathologic Function]
   783   C1301751:No effect [Qualitative Concept]
   783   C1411996:drug effect [Biologic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on basal glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159527:glucose uptake [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "our above-mentioned conclusions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707478:Conclusions [Idea or Concept]
Processing 00000000.tx.105: However, MCC-555 significantly enhanced the stimulatory action of the hormone. 

Phrase: "However,"

Phrase: "MCC-555 significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the stimulatory action of the hormone."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]
Processing 00000000.tx.106: Under these conditions, the incremental increase in glucose transport was enhanced 2.8-fold from 125 to 348 pmol 3-OMG/106 cells10 sec (Fig. 2, lower panel, right). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the incremental increase in glucose transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "2.8-fold from 125"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "to 348 pmol 3-OMG/106 cells10 sec (Fig. 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C0349966:Fig [Food]
   791   C0439192:pmol [Quantitative Concept]
   791   C1337208:FIG [Food]
   791   C1417949:OMG [Gene or Genome]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.107: These data show that low concentrations of the drug are able to produce a marked sensitization of insulin action in this cellular system. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that low concentrations of the drug"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0678756:concentrations drug [Quantitative Concept]
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "produce"

Phrase: "a marked sensitization of insulin action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1325847:Sensitisation [Mental Process]

Phrase: "in this cellular system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.108: The requirement of longer incubation periods at 10 M may be indicative of a slow uptake process of the drug and/or the requirement of intracellular metabolism to achieve drug action. 

Phrase: "The requirement of longer incubation periods"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514873:Requirement [Functional Concept]

Phrase: "at 10 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "indicative of a slow uptake process of the drug"

Phrase: "and/or"

Phrase: "the requirement of intracellular metabolism to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514873:Requirement [Functional Concept]

Phrase: "achieve"

Phrase: "drug action."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0728867:Drug action [Pathologic Function]
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1254351:Drug [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.109: It is worth noting that other TZD, such as troglitazone, were unable to produce acute sensitization of insulin action in cardiomyocytes even at high concentrations (50 M) applied to the cells for 3 h (9). 

Phrase: "It"

Phrase: "is worth noting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "other TZD,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "such as troglitazone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "produce"

Phrase: "acute sensitization of insulin action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1325847:Sensitisation [Mental Process]

Phrase: "in cardiomyocytes even"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0225828:Cardiomyocytes [Cell]

Phrase: "at high concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(50"

Phrase: "M)"

Phrase: "applied to the cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0185125:Applied [Health Care Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1632850:Apply [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1879355:Apply [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "for 3 h (9"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0442760:3/9 [Finding]
   901   C0041119:3 H [Element, Ion, or Isotope]
   901   C0067456:H-9 [Organic Chemical,Pharmacologic Substance]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439086:<3 [Quantitative Concept]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.110: This may be indicative of potential differences between MCC-555 and other TZD concerning molecular action mechanisms, at least in this cellular system. 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "indicative of potential differences"

Phrase: "between MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "other TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "molecular action mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in this cellular system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.111: View larger version (48K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(48K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.112: Effect of MCC-555 on basal and insulin-stimulated glucose transport. 

Phrase: "Effect of MCC-555"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated glucose transport."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0178666:glucose transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]
Processing 00000000.tx.113: Freshly isolated cardiomyocytes (4 x 105 cells/ml) were preincubated for 30 min (upper panel) or 2 h (lower panel) with the indicated concentrations of MCC-555. 

Phrase: "Freshly isolated cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0225828:Cardiomyocytes [Cell]

Phrase: "(4 x 105 cells/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2699156:Cells/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "preincubated for 30 min (upper panel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0441833:Panel [Idea or Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1282910:Upper [Spatial Concept]
   753   C1999270:Panel [Intellectual Product]
   753   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "2 h (lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "with the indicated concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of MCC-555."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.114: Cells were then stimulated with insulin for 5 min, and the transport of 3-OMG (final concentration, 100 mol/l) was determined over a 10-sec assay period, as outlined in Materials and Methods. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the transport of 3-OMG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "(final concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "100 mol/l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "was"

Phrase: "determined over a 10-sec assay period,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0439531:/period [Temporal Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1948053:Period [Temporal Concept]

Phrase: "as"

Phrase: "outlined in Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.115: Data are presented as a percentage of basal transport rates (left panels) or as absolute transport rates (right panels) and are the mean  SEM of three to six separate experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as a percentage of basal transport rates"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   750   C1648294:Basal rate [Clinical Attribute]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0205112:Basal [Spatial Concept]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0449450:Presented [Idea or Concept]
   744   C1317949:Transport [Manufactured Object]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   744   C3495449:transport [Medical Device]
   711 E C0150312:Present [Quantitative Concept]
   711   C0871208:Rate [Activity]
   711   C1521828:Rate [Quantitative Concept]

Phrase: "(left panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or as absolute transport rates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0005528:Transport, NOS [Cell Function]
   760   C0205344:Absolute [Qualitative Concept]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "(right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "the mean  SEM of three to six separate experiments."
Processing 00000000.tx.116: *, Significantly different from corresponding control at P < 0.005; 

Phrase: "*,"

Phrase: "Significantly different from corresponding control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "at P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.117: **, P < 0.05.  

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.118: Studies on insulin signaling The data reported to date suggested that MCC-555 could be able to modify certain elements of the insulin signaling cascade, possibly by enhancing insulin-induced protein tyrosine phosphorylations and/or modifications of downstream signaling. 

Phrase: "Studies on insulin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "reported to date"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   858   C1302584:Reported Date [Temporal Concept]
   790   C0011008:Date [Temporal Concept]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C2348077:Date [Food]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "certain elements of the insulin signaling cascade,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0013879:Elements [Element, Ion, or Isotope]
   714 E C1705248:Element [Conceptual Entity]

Phrase: "possibly by enhancing insulin-induced protein tyrosine phosphorylations"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   754   C1519726:Tyrosine Phosphorylation [Molecular Function]
   750   C1158886:Protein phosphorylation [Molecular Function]
       E   Phosphorylation
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0031715:Phosphorylations [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0205263:Induced [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2362652:Possibly [Qualitative Concept]
   711   C2349975:Enhance [Activity]

Phrase: "and/or"

Phrase: "modifications of downstream signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.119: We therefore analyzed the tyrosine phosphorylation of the insulin receptor (IR) -subunit and of IRS-1 in response to insulin (100 nM) using the 30-min preincubation protocol with 100 M MCC-555 outlined in Fig. 

Phrase: "We therefore"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the tyrosine phosphorylation of the insulin receptor (IR) -subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1519726:Tyrosine Phosphorylation [Molecular Function]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "and of IRS-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   790   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   790   C1334133:INSULIN RECEPTOR [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1515981:And [Idea or Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1710236:Substrate [Manufactured Object]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 30-min preincubation protocol with 100 M MCC-555"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0065772:MCC protocol [Therapeutic or Preventive Procedure]
   739   C0442711:Protocol [Intellectual Product]
   739   C1507394:Protocol [Intellectual Product]
   739   C1522729:Protocol [Intellectual Product]
   739   C2348563:Protocol [Intellectual Product]

Phrase: "outlined in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.120: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.121: A representative Western blot of the tyrosine-phosphorylated IR -subunit is presented in Fig. 

Phrase: "A representative Western blot of the tyrosine-phosphorylated IR -subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   756   C0949466:Western Blot [Laboratory Procedure]
   738   C1705493:Western [Spatial Concept]

Phrase: "is"

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.122: 3 (upper panel). 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.123: Insulin produced a marked increase (3.3  0.2-fold; n = 3) in the autophosphorylation of the IR, with a slight, but insignificant (P > 0.05), modification in the presence of MCC-555 (3.8  0.2-fold; n = 3). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "produced"

Phrase: "a marked increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "(3.3  0.2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "; n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in the autophosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813988:autophosphorylation [Molecular Function]

Phrase: "of the IR,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with a slight,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2937276:Slight [Qualitative Concept]
  1000   C2945599:Slight [Qualitative Concept]

Phrase: "but"

Phrase: "insignificant"

Phrase: "(P > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "modification in the presence of MCC-555"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]

Phrase: "(3.8  0.2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "; n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.124: When MCC-555 was applied in the absence of insulin, no autophosphorylation of the IR became detectable (Fig. 3, upper panel). 

Phrase: "When"

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "applied in the absence of insulin,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0185125:Applied [Health Care Activity]
   753   C0332197:absence [Quantitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1689985:Absence [Anatomical Abnormality]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: "no autophosphorylation of the IR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0813988:autophosphorylation [Molecular Function]

Phrase: "became"

Phrase: "detectable"

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.125: Comparable results were obtained at lower insulin concentrations (0.1 nM; data not shown). 

Phrase: "Comparable results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained at lower insulin concentrations"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0441994:Lower [Spatial Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1548802:Lower [Body Location or Region]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2003888:Lower [Activity]
   751   C0020459:INSULIN INCREASE [Disease or Syndrome]
   726 E C1446561:Concentration [Quantitative Concept]
   726 E C1706701:Obtain [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(0.1 nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: View larger version (44K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.127: Insulin-activated tyrosine phosphorylation of IR and IRS-1 in the absence or presence of MCC-555. 

Phrase: "Insulin-activated tyrosine phosphorylation of IR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "IRS-1 in the absence"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   778   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   778   C1334133:INSULIN RECEPTOR [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1710236:Substrate [Manufactured Object]

Phrase: "or"

Phrase: "presence of MCC-555."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.128: Cardiomyocytes were incubated in the absence or presence of 100 M MCC-555 for 30 min and subsequently stimulated with insulin (10-7 or 10-10 M) for 5 min. 

Phrase: "Cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "were"

Phrase: "incubated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of 100 M MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "subsequently"

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10-7"

Phrase: "or"

Phrase: "10-10"

Phrase: "M) for 5 min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1440942:M-5 [Immunologic Factor]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0702093:/min [Temporal Concept]
Processing 00000000.tx.129: After lysis, either IR (upper panel) or IRS-1 (lower panel) were immunoprecipitated, immune complexes were solubilized in Laemmli buffer, and submitted to separation by SDS-PAGE on gradient gels. 

Phrase: "After lysis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024348:Lysis [Pathologic Function]
  1000   C1536403:lysis [Cell Function]
   928 E C0439680:Lytic [Qualitative Concept]

Phrase: "either IR"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ","

Phrase: "immune complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003313:Immune Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439662:Immune [Functional Concept]
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "solubilized in Laemmli buffer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0258024:Laemmli buffer [Organic Chemical]
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "submitted to separation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0036679:Separation [Pathologic Function]
   790   C0237868:Separation [Social Behavior]
   790   C1515023:Submitted [Functional Concept]
   790   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "by SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "on gradient gels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]
Processing 00000000.tx.130: Immunoblotting was then performed using an antiphosphotyrosine antibody coupled to alkaline phosphatase, as outlined in Materials and Methods. 

Phrase: "Immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antiphosphotyrosine antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "coupled to alkaline phosphatase,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1149880:phosphatase [Molecular Function]
   770   C1948027:Coupled [Functional Concept]
   770   C1979842:Alkaline [Qualitative Concept]
   737 E C0010222:couple [Family Group]

Phrase: "as"

Phrase: "outlined in Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.131: Substrate was added for appropriate color development, and visualized signals were quantified using BioImage whole band analysis software. 

Phrase: "Substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "was"

Phrase: "added for appropriate color development,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0009393:Color [Natural Phenomenon or Process]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1524062:Added [Functional Concept]
   760   C1527148:Development [Functional Concept]
   760   C1548787:Appropriate [Qualitative Concept]
   760   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   760   C1705245:Color [Pharmacologic Substance]
   726 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "visualized signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BioImage whole band analysis software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.132: Representative experiments of three performed are shown.  

Phrase: "Representative experiments of three"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.133: Phosphotyrosine analysis of IRS-1 immunoprecipitates from cardiomyocytes indicated the presence of a Tyr-phosphorylated protein with a molecular mass between 160170 kDa (Fig. 3, lower panel), previously identified as IRS-1 in these cells (20). 

Phrase: "Phosphotyrosine analysis of IRS-1 immunoprecipitates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "from cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the presence of a Tyr-phosphorylated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "with a molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]

Phrase: "between 160170 kDa (Fig. 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1532717:kDa [Quantitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "previously"

Phrase: "identified as IRS-1"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   882   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   790   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   790   C1334133:INSULIN RECEPTOR [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205396:Identified [Qualitative Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1710236:Substrate [Manufactured Object]

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.134: Tyr phosphorylation of IRS-1 was increased in response to insulin to the same level in both the absence and presence of MCC-555 (151  7% vs. 158  18% of the control value, respectively; P > 0.05; n = 3). 

Phrase: "Tyr phosphorylation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "increased in response"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "to the same level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "in both"

Phrase: "the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "presence of MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(151  7%"

Phrase: "vs. 158  18% of the control value,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243148:control [Qualitative Concept]
   748   C1522609:Value [Quantitative Concept]
   748   C1550141:Control [Substance]
   748   C1704629:VS [Idea or Concept]
   748   C1704752:VS [Intellectual Product]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "respectively"

Phrase: "; P > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.135: Comparable results were obtained at higher insulin concentrations (data not shown). 

Phrase: "Comparable results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained at higher insulin concentrations"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C0020459:high insulin [Disease or Syndrome]
           INSULIN INCREASE
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C1301820:Obtained [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726 E C1446561:Concentration [Quantitative Concept]
   726 E C1706701:Obtain [Activity]
   726   C2700149:HIGH [Intellectual Product]
   709   C0557899:Height increased [Finding]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.136: It has now been recognized that PI 3-kinase represents an essential element for downstream insulin signaling to the glucose transporter GLUT4 in all major target tissues (29). 

Phrase: "It"

Phrase: "has"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "been"

Phrase: "recognized"

Phrase: "that PI 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an essential element for downstream insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C1705248:Element [Conceptual Entity]

Phrase: "to the glucose transporter GLUT4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420175:GLUT4 [Gene or Genome]
   827   C2982484:GLUT4 [Gene or Genome]
   734   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in all major target tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0040300:Tissues [Tissue]
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.137: We therefore investigated the effect of MCC-555 on the IRS-1-associated PI 3-kinase activity in cardiomyocytes stimulated with physiological insulin concentrations (Fig. 4). 

Phrase: "We therefore"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of MCC-555"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the IRS-1-associated PI 3-kinase activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   895   C1150623:insulin receptor activity [Molecular Function]
   891   C1145751:insulin activity [Molecular Function]
   879   C1152633:receptor activity [Molecular Function]
   849   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   834   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   807   C1150423:kinase activity [Molecular Function]
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   711   C2350410:Insulin Receptor Substrate-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "stimulated with physiological insulin concentrations"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0205463:Physiological [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   726 E C1446561:Concentration [Quantitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.138: A representative autoradiogram of the TLC of the PI 3-kinase products using phosphatidylinositol as a substrate is shown in Fig. 

Phrase: "A representative autoradiogram of the TLC of the PI 3-kinase products"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "phosphatidylinositol as a substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   770   C2348046:Phosphatidylinositol [Lipid]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.139: 4 (upper panel). 

Phrase: "4"

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.140: As can be clearly seen from the data, the insulin-induced enzyme activity is strongly enhanced by preincubating the cells with the drug. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "clearly"

Phrase: "seen from the data,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205397:Seen [Qualitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "the insulin-induced enzyme activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C1145751:insulin activity [Molecular Function]
   861   C0243102:enzyme activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "strongly"

Phrase: "enhanced by preincubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2349975:Enhanced [Activity]

Phrase: "the cells with the drug."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:THE CELL [Cell]
           Cells
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.141: Quantification of three separate experiments (Fig. 4, middle panel) indicated a more than 2-fold higher IRS-1-associated PI 3-kinase activity in the presence of 10 M MCC-555. 

Phrase: "Quantification of three separate experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than 2-fold higher IRS-1-associated PI 3-kinase activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   864   C1150623:insulin receptor activity [Molecular Function]
   862   C1145751:insulin activity [Molecular Function]
   853   C1152633:receptor activity [Molecular Function]
   827   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   818   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   799   C1150423:kinase activity [Molecular Function]
   787   C0205177:Activity [Functional Concept]
   787   C0439167:% activity [Quantitative Concept]
   787   C0441655:Activity [Activity]
   787   C1561536:*Activity [Idea or Concept]
   705   C1519042:2-3 [Research Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10 M MCC-555."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.142: The same potentiation of insulin-stimulated PI 3-kinase activity was observed at 100 nM insulin (Fig. 4, middle panel). 

Phrase: "The same potentiation of insulin-stimulated PI 3-kinase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "observed at 100 nM insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1441672:Observed [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.143: The effect of MCC-555 was dose dependent; 

Phrase: "The effect of MCC-555"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "dose dependent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512045:Dose-dependent [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: ";"
Processing 00000000.tx.144: it was maximal at 10 M using the 2-h protocol (Fig. 4, lower panel). 

Phrase: "it"

Phrase: "was"

Phrase: "maximal at 10 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205289:Maximal [Qualitative Concept]
   770   C0806909:Maximal [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 2-h protocol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.145: View larger version (24K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.146: Effects of MCC-555 on IRS-1-associated PI 3-kinase activity. 

Phrase: "Effects of MCC-555"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on IRS-1-associated PI 3-kinase activity."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   895   C1150623:insulin receptor activity [Molecular Function]
   891   C1145751:insulin activity [Molecular Function]
   879   C1152633:receptor activity [Molecular Function]
   849   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   834   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   807   C1150423:kinase activity [Molecular Function]
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   711   C2350410:Insulin Receptor Substrate-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.147: Upper panel, Cardiomyocytes were incubated for 2 h at 37 C with 100 M MCC-555. 

Phrase: "Upper panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "Cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "were"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C"

Phrase: "with 100 M MCC-555."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.148: Insulin (10-10 M) was then added to each sample for 5 min. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10-10"

Phrase: "M)"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to each sample"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0370003:Sample [Substance]
   770   C1524062:Added [Functional Concept]
   770   C2347026:Sample [Conceptual Entity]
   737 E C1883712:Add [Functional Concept]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.149: After solubilization, IRS-1 was immunoprecipitated as described in Materials and Methods. 

Phrase: "After solubilization,"

Phrase: "IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.150: The PI 3-kinase assay was then performed in the immunoprecipitate using [32P]ATP and PI as substrate. 

Phrase: "The PI 3-kinase assay"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   895 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "performed in the immunoprecipitate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0301871:Immunoprecipitate [Immunologic Factor]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "and"

Phrase: "PI as substrate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   790   C2348046:Phosphatidylinositol [Lipid]
Processing 00000000.tx.151: Lipid products were separated by TLC, and signals were visualized on a Fujix BAS 1000 BioImaging analyzer. 

Phrase: "Lipid products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by TLC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "visualized on a Fujix BAS 1000 BioImaging analyzer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0179038:Analyzer [Medical Device]
   744   C0234621:Visualized [Functional Concept]
   744   C0872020:bioimaging [Intellectual Product]
   744   C1706246:Analyzer [Manufactured Object]
   744   C1862288:BAS [Clinical Attribute]
Processing 00000000.tx.152: Middle panel, Quantification of autoradiographs was performed using BioImaging analysis software. 

Phrase: "Middle panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "Quantification of autoradiographs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantification [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BioImaging analysis software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.153: Results are expressed as a fold over basal PI 3-kinase activity measured in the absence of MCC-555 and insulin. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as a fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332462:Fold [Spatial Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "over basal PI 3-kinase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   888   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "measured in the absence of MCC-555"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   748   C0332197:absence [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.154: All data were corrected for enzyme activity not inhibited by wortmannin. 

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "corrected for enzyme activity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0243102:enzyme activity [Molecular Function]
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
   770   C0205177:Activity [Functional Concept]
   770   C0205202:Corrected [Qualitative Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737 E C2349182:Correct [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited by wortmannin."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
Processing 00000000.tx.155: The results shown are the mean  SEM of three or four separate experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the mean  SEM of three"

Phrase: "or"

Phrase: "four separate experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.156: Lower panel, Cardiomyocytes were preincubated with increasing concentrations of MCC-555 for 2 h, stimulated with insulin for 5 min, and processed for PI 3-kinase determination as outlined above. 

Phrase: "Lower panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "Cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "were"

Phrase: "preincubated with increasing concentrations of MCC-555"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   748   C0086045:Concentrations [Mental Process]
   748   C0442808:Increasing [Functional Concept]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 2 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "processed for PI 3-kinase determination"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   805 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1148554:determination [Laboratory Procedure]
   753   C1522240:Processed [Phenomenon or Process]
   753   C2348046:Phosphatidylinositol [Lipid]
   719 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "as outlined above."
Processing 00000000.tx.157: Data are the mean  SEM of three separate experiments.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "the mean  SEM of three separate experiments."
Processing 00000000.tx.158: The augmented insulin-stimulated PI 3-kinase activity in the presence of MCC-555 could not be explained by an increased association of the p85 regulatory subunit with IRS-1, as shown in the representative Western blot in Fig. 

Phrase: "The augmented insulin-stimulated PI 3-kinase activity in the presence"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   772   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   756   C1150423:kinase activity [Molecular Function]
   754   C1145751:insulin activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "of MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "explained by an increased association of the p85 regulatory subunit"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0004083:Association [Mental Process]
   739   C0205217:Increased [Quantitative Concept]
   739   C0220905:regulatory [Regulation or Law]
   739   C0439849:Association [Qualitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]
   739   C1704735:Regulatory [Conceptual Entity]
   739   C1711351:Subunit [Quantitative Concept]
   739   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C3541313:p85 [Gene or Genome]

Phrase: "with IRS-1,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as"

Phrase: "shown in the representative Western blot"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]
   753   C1882932:Representative [Activity]
   719   C1547282:Show [Intellectual Product]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.159: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.160: Insulin markedly stimulated the coimmunoprecipitation of p85 and IRS-1; 

Phrase: "Insulin markedly"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the coimmunoprecipitation of p85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.161: however, in four separate experiments only a slightly and insignificantly higher association of p85 to IRS-1 was detected in cardiomyocytes preincubated with MCC-555 (100 M) for 2 h. 

Phrase: "however,"

Phrase: "in four separate experiments only"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "a slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "and"

Phrase: "insignificantly higher association of p85"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "to IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "detected in cardiomyocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0225828:Cardiomyocytes [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "preincubated with MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "(100"

Phrase: "M) for 2 h."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   819   C2348952:H/m [Quantitative Concept]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.162: Total expression of p85 also remained unaffected (data not shown). 

Phrase: "Total expression of p85 also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "remained"

Phrase: "unaffected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.163: As PI 3-kinase activity was increased at least 2-fold by the drug (see Fig. 4), it can be concluded that MCC-555 modulates the intrinsic activity of PI 3-kinase associated with IRS-1 without affecting recruitment of the enzyme to the docking protein. 

Phrase: "As PI 3-kinase activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   923   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "increased at least 2-fold"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205217:Increased [Quantitative Concept]
   760   C0332462:Fold [Spatial Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "by the drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "can"

Phrase: "be"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the intrinsic activity of PI 3-kinase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   840   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   800   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   774   C1150423:kinase activity [Molecular Function]
   748   C0205102:Intrinsic [Spatial Concept]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0439674:Intrinsic [Functional Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "associated with IRS-1"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   882   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   790   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1334133:INSULIN RECEPTOR [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1710236:Substrate [Manufactured Object]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "without affecting recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2949735:Recruitment [Activity]

Phrase: "of the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "to the docking protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420414:DOCKING PROTEIN [Gene or Genome]
  1000   C1760028:docking protein [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.164: View larger version (34K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.165: Association of p85 subunit of PI 3-kinase to IRS-1 in response to insulin in the absence or presence of MCC-555. 

Phrase: "Association of p85 subunit of PI 3-kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "to IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of MCC-555."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.166: After preincubation with MCC-555 (100 M; for 2 h), the cells were stimulated with insulin (10-7 M) for 5 min. 

Phrase: "After preincubation"

Phrase: "with MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "(100 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ";"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10-7"

Phrase: "M) for 5 min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1440942:M-5 [Immunologic Factor]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0702093:/min [Temporal Concept]
Processing 00000000.tx.167: IRS-1 was immunoprecipitated as described in Fig. 

Phrase: "IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.168: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.169: The immunopellet was separated by SDS-PAGE and immunoblotted with a polyclonal anti-p85 antibody. 

Phrase: "The immunopellet"

Phrase: "was"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotted with a polyclonal anti-p85 antibody."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C3541313:p85 [Gene or Genome]
   714   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.170: Filters were incubated with [125I]protein A, and signals were visualized on a phosphorimager. 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[125I"

Phrase: "]protein A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "visualized on a phosphorimager."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.171: One representative experiment of four is shown.  

Phrase: "One representative experiment of four"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0681814:Experiment [Research Activity]
   760   C1706386:Experiment [Conceptual Entity]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.172: Involvement of protein synthesis in the action of MCC-555 As outlined above, the transcription factor PPAR is considered to represent a major target for the intracellular action of TZD. 

Phrase: "Involvement of protein synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "in the action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "of MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "As"

Phrase: "outlined above,"

Phrase: "the transcription factor PPAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   883   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   883   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a major target for the intracellular action of TZD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1521840:Target [Functional Concept]
   742   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.173: This protein is expressed at a high level in adipose tissue (17), but more recent studies have also reported expression of PPAR in heart and skeletal muscle (30). 

Phrase: "This protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "expressed at a high level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "more recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also reported expression of PPAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.174: Using human adipocytes as a reference tissue, we have now performed Western blotting analysis of PPAR to confirm the expression of this protein in our cardiomyocyte preparation. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "human adipocytes as a reference tissue,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0206131:Adipocytes [Cell]

Phrase: "we"

Phrase: "have"

Phrase: "now performed Western blotting analysis of PPAR to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0949466:Western blot analysis [Laboratory Procedure]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the expression of this protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in our cardiomyocyte preparation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.175: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.176: 6, the PPAR antiserum recognized a protein band with a molecular mass of about 5358 kDa in adipocytes and cardiomyocytes. 

Phrase: "6,"

Phrase: "the PPAR antiserum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "recognized"

Phrase: "a protein band with a molecular mass of about 5358 kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0230715:A band [Cell Component]
   738   C0175723:Band [Medical Device]
   738   C0439645:Band [Spatial Concept]
   738   C1521913:band [Cell Component]

Phrase: "in adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "and"

Phrase: "cardiomyocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]
Processing 00000000.tx.177: The abundance of PPAR in cardiocytes can be roughly estimated to be 2030% of that in adipocytes (Fig. 6). 

Phrase: "The abundance of PPAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2346714:Abundance [Qualitative Concept]

Phrase: "in cardiocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0225828:Cardiocyte [Cell]
   966   C2333889:Cardiocyte [Classification]

Phrase: "can"

Phrase: "be"

Phrase: "roughly"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "2030% of that"

Phrase: "in adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.178: View larger version (27K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.179: Western blot analysis of PPAR expression. 

Phrase: "Western blot analysis of PPAR expression."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1705493:Western [Spatial Concept]
Processing 00000000.tx.180: Whole cell extracts were prepared from human adipocytes (Adi) or rat cardiomyocytes (Cardi) as outlined in Materials and Methods. 

Phrase: "Whole cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared from human adipocytes (Adi) or rat cardiomyocytes (Cardi)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0086418:Human [Human]
   748   C0206131:Adipocytes [Cell]
   748   C0225828:Cardiomyocytes [Cell]
   714   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "outlined in Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.181: Proteins were separated by SDS-PAGE and immunoblotted with a polyclonal PPAR antibody. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotted with a polyclonal PPAR antibody."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   800   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   800   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   764   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   762   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1879547:Activated [Activity]
   742   C3546463:peroxisomal [Cell Component]
   729   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   708   C0020985:Immunoblot [Laboratory Procedure]
   708 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.182: Filters were then incubated with horseradish peroxidase-conjugated goat antirabbit antibody and processed for ECL detection. 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with horseradish peroxidase-conjugated goat antirabbit antibody"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0018019:goat [Mammal]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0330510:Horseradish [Food]
   744   C0522529:Conjugated [Spatial Concept]
   744   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   744   C1110641:Horseradish [Plant]
   744   C1265549:goat [Mammal]
   744   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1510458:Goat [Mammal]

Phrase: "and"

Phrase: "processed for ECL detection."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1332684:ECL [Gene or Genome]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
   770   C1522240:Processed [Phenomenon or Process]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.183: Four experiments with similar results were performed.  

Phrase: "Four experiments with similar results"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0681814:Experiments [Research Activity]
   739   C2825142:Experimental Result [Finding]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.184: To assess whether the acute effects of MCC-555 on insulin-stimulated glucose transport might involve protein synthesis and thus most probably the PPAR pathway, we preincubated the cardiomyocytes with cycloheximide before performing the 30-min incubation protocol with MCC-555. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "the acute effects of MCC-555"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin-stimulated glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0178666:glucose transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]

Phrase: "might"

Phrase: "involve"

Phrase: "protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "thus most probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0750492:Probably [Idea or Concept]

Phrase: "the PPAR pathway,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   753   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "we"

Phrase: "preincubated"

Phrase: "the cardiomyocytes with cycloheximide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0225828:Cardiomyocytes [Cell]

Phrase: "before performing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0884358:Perform [Functional Concept]
   966   C2947996:Perform [Pharmacologic Substance]

Phrase: "the 30-min incubation protocol with MCC-555."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0065772:MCC protocol [Therapeutic or Preventive Procedure]
   744   C0442711:Protocol [Intellectual Product]
   744   C1507394:Protocol [Intellectual Product]
   744   C1522729:Protocol [Intellectual Product]
   744   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.185: As presented in Fig. 

Phrase: "As"

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.186: 7 and as expected, cycloheximide was essentially unable to alter the insulin-stimulated glucose transport rate. 

Phrase: "7"

Phrase: "and"

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "was"

Phrase: "essentially unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1299582:Unable [Finding]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the insulin-stimulated glucose transport rate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0871208:Rate [Activity]
   804   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.187: However, potentiation of insulin action by MCC-555 was completely abolished by inhibition of protein synthesis (Fig. 7). 

Phrase: "However,"

Phrase: "potentiation of insulin action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "by MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished by inhibition of protein synthesis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   820   C1519619:Protein Synthesis Inhibition [Genetic Function]
   790   C0597295:Protein Synthesis [Molecular Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220781:synthesis [Biologic Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C1883254:Synthesis [Activity]
   753   C3463820:Inhibition [Activity]
   748 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.188: These findings suggest the existence of a very rapidly induced protein that modulates insulin action at the level of PI 3-kinase. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the existence of a very rapidly induced protein"

Phrase: "that"

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "insulin action at the level of PI 3-kinase."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0202098:Insulin level [Laboratory Procedure]
   762   C0428405:insulin level [Laboratory or Test Result]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0441472:Action [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C3266814:Action [Activity]
Processing 00000000.tx.189: It should be noted that initial experiments revealed a 50-fold lower affinity of MCC-555 for PPAR compared with the high affinity TZD ligand BRL 49653 (31) despite a more potent in vivo action profile of MCC-555. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that initial experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a 50-fold lower affinity of MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for PPAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   982   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   982   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "compared with the high affinity TZD ligand BRL 49653"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   764   C0289314:BRL 49653 [Organic Chemical,Pharmacologic Substance]
   742   C0023688:Ligand [Chemical]
   742   C0205250:High [Qualitative Concept]
   742   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   742   C1299351:High [Qualitative Concept]
   742   C1412820:BRL [Gene or Genome]
   742   C1510827:Affinity [Natural Phenomenon or Process]
   742   C1707455:Compared [Activity]
   742   C2700149:HIGH [Intellectual Product]
   708 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   708 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "despite a more potent in vivo action profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1979963:Profile [Laboratory Procedure]
   799   C2003903:Profile [Functional Concept]

Phrase: "of MCC-555."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.190: Most interestingly, it was observed that MCC-555 is able to function as a context-dependent antagonist or partial agonist for PPAR, making it unique among TZDs (31). 

Phrase: "Most interestingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "it"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "function as a context-dependent antagonist"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0031843:function [Physiologic Function]
   753   C0231491:Antagonist [Organ or Tissue Function]
   753   C0449255:Context [Finding]
   753   C0542341:Function [Functional Concept]
   753   C0542559:Context [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1705273:Function [Intellectual Product]
   753   C3244310:dependent [Functional Concept]

Phrase: "or"

Phrase: "partial agonist for PPAR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2987634:Agonist [Pharmacologic Substance]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "it unique among TZDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710548:Unique [Qualitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.191: View larger version (43K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.192: Cycloheximide blocks the potentiation of insulin action by MCC-555. 

Phrase: "Cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the potentiation of insulin action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "by MCC-555."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.193: Cardiomyocytes were subjected to the indicated incubation conditions using insulin (10-7 M) for 5 min and MCC-555 (100 M) and cycloheximide (1 mM) for 30 min. 

Phrase: "Cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "were"

Phrase: "subjected to the indicated incubation conditions"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C1444656:Indicated [Finding]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1705253:Condition [Conceptual Entity]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10-7"

Phrase: "M) for 5 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1440942:M-5 [Immunologic Factor]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "(100"

Phrase: "M)"

Phrase: "and"

Phrase: "cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(1 mM) for 30 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1418486:MM-1 [Gene or Genome]
   797   C3642211:mm/min [Quantitative Concept]
Processing 00000000.tx.194: Initial rates of 3-OMG transport were then determined, as outlined in Fig. 

Phrase: "Initial rates of 3-OMG transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205265:Initial [Temporal Concept]
   753   C1279901:Initial [Qualitative Concept]
   753   C1555582:Initial [Idea or Concept]
   753   C1705685:INITIAL [Functional Concept]
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "determined"

Phrase: ","

Phrase: "as"

Phrase: "outlined in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.195: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.196: Glucose transport is expressed as a percentage of basal uptake, which was determined in the absence of any addition. 

Phrase: "Glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "expressed as a percentage of basal uptake,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205112:Basal [Spatial Concept]
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "which"

Phrase: "was"

Phrase: "determined in the absence of any addition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1883712:Addition [Functional Concept]
Processing 00000000.tx.197: Data are the mean  SEM (n = 34). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "the mean  SEM (n = 34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0444504:Mean [Quantitative Concept]
   812   C2347634:Mean [Quantitative Concept]
   812   C2348143:Mean [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.198: *, Significantly different from transport stimulation determined in the presence of cycloheximide (P = 0.0187).  

Phrase: "*,"

Phrase: "Significantly different from transport stimulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "determined in the presence of cycloheximide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(P = 0.0187"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.199: Effects of MCC-555 in cardiomyocytes from obese Zucker rats The data reported above highlight the strong insulin-sensitizing potency of MCC-555 at the level of glucose transport and insulin signaling. 

Phrase: "Effects of MCC-555"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "from obese Zucker rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "highlight"

Phrase: "the strong insulin-sensitizing potency of MCC-555"

Phrase: "at the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "insulin signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.200: To evaluate whether this drug action is able to overcome insulin resistance, we isolated cardiomyocytes from genetically (fa/fa) obese Zucker rats. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "whether"

Phrase: "this drug action"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0728867:Drug action [Pathologic Function]
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1254351:Drug [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "cardiomyocytes from genetically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0225828:Cardiomyocytes [Cell]

Phrase: "(fa/fa) obese Zucker rats."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0034719:Rats, Zucker [Mammal]
   804   C0028754:Obese [Disease or Syndrome]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
   804   C2700303:Zucker [Mammal]
Processing 00000000.tx.201: We recently reported (20) a largely blunted half-maximal response of glucose transport in these cells with a marked rightward shift of the dose-response curve for insulin. 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(20"

Phrase: ")"

Phrase: "a largely blunted half-maximal response of glucose transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "with a marked rightward shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333051:Shift [Functional Concept]
   827   C2347509:Shift [Phenomenon or Process]

Phrase: "of the dose-response curve"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0683162:dose-response curve [Quantitative Concept]
   827   C0178602:Dose [Quantitative Concept]
   827   C0205134:Curve [Spatial Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1114758:Dose # [Clinical Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "for insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.202: This was explained by hyperphosphorylation of IRS-1 on Ser/Thr and a defective activation of PI 3-kinase. 

Phrase: "This"

Phrase: "was"

Phrase: "explained by hyperphosphorylation of IRS-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   770   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   770   C1334133:INSULIN RECEPTOR [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1710236:Substrate [Manufactured Object]

Phrase: "on Ser/Thr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "a defective activation of PI 3-kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]
Processing 00000000.tx.203: In light of these findings we investigated whether MCC-555 was able to restore the normal response of the glucose transporter using a short term preincubation of cardiomyocytes isolated from obese Zucker rats. 

Phrase: "In light of these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "restore"

Phrase: "the normal response of the glucose transporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a short term preincubation of cardiomyocytes"

Phrase: "isolated from obese Zucker rats."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0034719:Rats, Zucker [Mammal]
   760   C0028754:Obese [Disease or Syndrome]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C2700303:Zucker [Mammal]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.204: As presented in Fig. 

Phrase: "As"

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.205: 8 (upper panel), these cells are completely insulin resistant at 0.03 nM insulin, whereas a 1.5- to 2-fold response is normally observed in control cells at this hormone concentration (see also Fig. 2). 

Phrase: "8"

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "completely insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resistant at 0.03 nM insulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332325:Resistant [Functional Concept]
   753   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "whereas"

Phrase: "a 1.5-"

Phrase: "to 2-fold response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "normally"

Phrase: "observed in control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0007634:Cells [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "at this hormone concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "also Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.206: Preincubation with MCC-555 completely ameliorated the insulin resistance and produced a substantial increase in insulin-mediated 3-OMG uptake from 26 to 219 pmol/106 cells10 sec (Fig. 8, lower panel) at this low physiological concentration. 

Phrase: "Preincubation with MCC-555 completely"

Phrase: "ameliorated"

Phrase: "the insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "produced"

Phrase: "a substantial increase in insulin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0020459:INSULIN INCREASE [Disease or Syndrome]
   760   C0442805:Increase [Functional Concept]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "3-OMG uptake from 26"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "to 219 pmol/106 cells10 sec (Fig. 8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0349966:Fig [Food]
   795   C0439192:pmol [Quantitative Concept]
   795   C1337208:FIG [Food]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "at this low physiological concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.207: At higher concentrations of the hormone, 3-OMG uptake was also significantly elevated from 300513 pmol/106 cells10 sec (Fig. 8, lower panel). 

Phrase: "At higher concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of the hormone,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormone [Hormone]
   928 E C0458083:Hormonal [Qualitative Concept]

Phrase: "3-OMG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "also significantly"

Phrase: "elevated from 300513 pmol/106 cells10 sec (Fig. 8,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0205250:Elevated [Qualitative Concept]
   742   C0349966:Fig [Food]
   742   C0439192:pmol [Quantitative Concept]
   742   C1337208:FIG [Food]
   742   C3163633:Elevated [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.208: This observation clearly indicates that MCC-555 is able to normalize and improve insulin action in a severe insulin-resistant state. 

Phrase: "This observation clearly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicates"

Phrase: "that MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "and"

Phrase: "improve"

Phrase: "insulin action in a severe insulin-resistant state."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0441472:Action [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C3266814:Action [Activity]
Processing 00000000.tx.209: View larger version (37K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.210: MCC-555 ameliorates insulin resistance in cardiomyocytes from obese Zucker rats. 

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "ameliorates"

Phrase: "insulin resistance in cardiomyocytes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from obese Zucker rats."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.211: Isolated cardiomyocytes from genetically obese (fa/fa) Zucker rats were preincubated with 100 M MCC-555 for 30 min, followed by incubation with the indicated concentrations of insulin for 5 min. 

Phrase: "Isolated cardiomyocytes from genetically obese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0225828:Cardiomyocytes [Cell]

Phrase: "(fa/fa) Zucker rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C2700303:Zucker [Mammal]

Phrase: "were"

Phrase: "preincubated with 100 M MCC-555"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with the indicated concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.212: 3-OMG transport was then determined as outlined in Fig. 

Phrase: "3-OMG transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "determined"

Phrase: "as"

Phrase: "outlined in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.213: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.214: Data are presented as a percentage of basal transport rates (upper panel) or as absolute transport rates (lower panel) and are the mean  SEM of three individual experiments, each performed in triplicate.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as a percentage of basal transport rates"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   750   C1648294:Basal rate [Clinical Attribute]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0205112:Basal [Spatial Concept]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0449450:Presented [Idea or Concept]
   744   C1317949:Transport [Manufactured Object]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   744   C3495449:transport [Medical Device]
   711 E C0150312:Present [Quantitative Concept]
   711   C0871208:Rate [Activity]
   711   C1521828:Rate [Quantitative Concept]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or as absolute transport rates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0005528:Transport, NOS [Cell Function]
   760   C0205344:Absolute [Qualitative Concept]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "the mean  SEM of three individual experiments,"

Phrase: "each"

Phrase: "performed in triplicate."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.215: As outlined above, we reported that the hyperphosphorylation of IRS-1 could be the underlying cause for the defective activation of PI 3-kinase in myocytes from obese Zucker rats (20). 

Phrase: "As"

Phrase: "outlined above,"

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the hyperphosphorylation of IRS-1"

Phrase: "could"

Phrase: "be"

Phrase: "the underlying cause for the defective activation of PI 3-kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0015127:cause [Functional Concept]
   738   C1524003:Cause [Conceptual Entity]

Phrase: "in myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596981:Myocytes [Cell]

Phrase: "from obese Zucker rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.216: We therefore investigated whether MCC-555 might be able to reduce this hyperphosphorylation of IRS-1. 

Phrase: "We therefore"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "might"

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "reduce"

Phrase: "this hyperphosphorylation of IRS-1."
Processing 00000000.tx.217: Cardiomyocytes were isolated from Zucker rats and labeled with [33P]orthophosphate for 2.5 h in the absence or presence of MCC-555. 

Phrase: "Cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "were"

Phrase: "isolated from Zucker rats"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0034719:Rats, Zucker [Mammal]
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C2700303:Zucker [Mammal]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[33P"

Phrase: "]orthophosphate for 2.5 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of MCC-555."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.218: As shown in our earlier work (20), for IRS-1 this in vitro labeling approach can be used to provide a valid estimate of the Ser/Thr phosphorylation state. 

Phrase: "As"

Phrase: "shown in our earlier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1279919:Early [Temporal Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "for IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "this in vitro labeling approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449445:Approach [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a valid estimate of the Ser/Thr phosphorylation state."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0750572:Estimate [Quantitative Concept]
Processing 00000000.tx.219: IRS-1 was then immunoprecipitated and analyzed by SDS-PAGE followed by autoradiography. 

Phrase: "IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "followed by autoradiography."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0004400:Autoradiography [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.220: The representative experiment shown in Fig. 

Phrase: "The representative experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.221: 9 indicates that the drug induces a substantial reduction in the phosphorylation state of IRS-1. 

Phrase: "9"

Phrase: "indicates"

Phrase: "that"

Phrase: "the drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a substantial reduction in the phosphorylation state of IRS-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0301630:Reduction [Natural Phenomenon or Process]
   736   C0392756:Reduction [Qualitative Concept]
   736   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.222: Quantification of three separate experiments showed that MCC-555 reduces the Ser/Thr phosphorylation of IRS-1 in cardiomyocytes from obese rats by about 50% (P = 0.002). 

Phrase: "Quantification of three separate experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "reduces"

Phrase: "the Ser/Thr phosphorylation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "in cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "from obese rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "by about 50%"

Phrase: "(P = 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.223: View larger version (43K): [in this window] [in a new window]  Figure 9. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 9."
Processing 00000000.tx.224: Effect of MCC-555 on the phosphorylation state of IRS-1. 

Phrase: "Effect of MCC-555"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the phosphorylation state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "of IRS-1."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.225: Cardiomyocytes (1 x 106 cells/ml) from obese Zucker rats were labeled with [33P]orthophosphate for 2.5 h at 37 C, as described in Materials and Methods. 

Phrase: "Cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "(1 x 106 cells/ml) from obese Zucker rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C2699156:Cells/mL [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[33P"

Phrase: "]orthophosphate for 2.5 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "at 37 C,"

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.226: Cells were subsequently lysed, and IRS-1 was immunoprecipitated and analyzed by SDS-PAGE and autoradiography. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "autoradiography."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.227: A representative experiment of three performed is shown.   

Phrase: "A representative experiment of three"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0681814:Experiment [Research Activity]
   760   C1706386:Experiment [Conceptual Entity]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.228: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  TZD compounds have been recognized to function as insulin sensitizers (1, 2), and the rapidly growing family of these drugs (24, 32) might be considered the most promising approach for novel therapy of different states of insulin resistance. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TZD compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "have"

Phrase: "been"

Phrase: "recognized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "function as insulin sensitizers"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705273:Function [Intellectual Product]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "growing"

Phrase: "family of these drugs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Family [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "(24,"

Phrase: "32"

Phrase: ")"

Phrase: "might"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the most promising approach for novel therapy of different states of insulin resistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.229: To date, the vast majority of available data suggests that these compounds do not acutely modify the insulin signaling cascade and that long term incubations are required to produce the insulin-sensitizing effects (1, 2, 8, 9, 10, 16, 33, 34). 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "the vast majority of available data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "do"

Phrase: "not acutely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the insulin signaling cascade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2611812:signaling cascade [Cell Function]
   827   C1707310:Cascade [Manufactured Object]

Phrase: "and"

Phrase: "that long term incubations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0443252:Long-term [Temporal Concept]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "the insulin-sensitizing effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "8,"

Phrase: "9,"

Phrase: "10,"

Phrase: "16,"

Phrase: "33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.230: MCC-555 is a novel TZD exhibiting a very high in vivo potency in rodent models of insulin resistance (24). 

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "a novel TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   827 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   827 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "a very high in vivo potency in rodent"

Phrase: "models of insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3161035:Model [Intellectual Product]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.231: A key finding of the present study consists in the observation that this TZD is able to acutely sensitize cardiac glucose uptake 2- to 3-fold at physiological insulin concentrations (3 x 10-11 M), without any modification of the basal transport rate. 

Phrase: "A key finding of the present study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "consists in the observation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0332529:CONSIST [Qualitative Concept]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that"

Phrase: "this TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "is"

Phrase: "able to acutely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "sensitize"

Phrase: "cardiac glucose uptake 2-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]
   812   C1522601:Cardiac [Spatial Concept]

Phrase: "to 3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "at physiological insulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(3 x 10-11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: "M)"

Phrase: ","

Phrase: "without any modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "of the basal transport rate."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1648294:Basal rate [Clinical Attribute]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0871208:Rate [Activity]
   827   C1317949:Transport [Manufactured Object]
   827   C1521828:Rate [Quantitative Concept]
   827   C3495449:transport [Medical Device]
Processing 00000000.tx.232: We recently reported completely different observations using another TZD, troglitazone, in that short term incubations of cardiomyocytes with the drug, even at very high concentrations, did not produce any effect in these cells (9). 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "completely different observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0302523:observations [Research Activity]
   827   C0700325:observations [Health Care Activity]
   827   C3244290:observations [Functional Concept]
   793 E C1964257:Observation [Diagnostic Procedure]
   743 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "another TZD,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "troglitazone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "in that short term incubations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0443303:Short-term [Temporal Concept]

Phrase: "of cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "with the drug,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "even at very high concentrations,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0442804:Very high [Finding]
   760   C0086045:Concentrations [Mental Process]
   760   C0205250:High [Qualitative Concept]
   760   C0442824:Very [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "produce"

Phrase: "any effect in these cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.233: Instead, as consistently reported in cultured muscle and adipose cells, chronic exposure to TZD results in enhanced expression of glucose transporters GLUT1 and GLUT4, leading to a higher basal glucose uptake rate and possibly mediating the insulin-sensitizing effects of the drugs (9, 16, 33, 34, 35). 

Phrase: "Instead,"

Phrase: "as"

Phrase: "consistently"

Phrase: "reported in cultured muscle"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0026845:Muscle [Tissue]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "adipose cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0206131:adipose cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "chronic exposure to TZD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0205191:chronic [Temporal Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "results in enhanced expression of glucose transporters GLUT1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1274040:Result [Functional Concept]
   744   C1335837:GLUT1 [Gene or Genome]
   744   C1504631:Glut-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1546471:Result [Idea or Concept]
   744   C1705603:GLUT1 [Gene or Genome]
   744   C2349975:Enhanced [Activity]
   744   C2825142:Result [Finding]
   737   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GLUT4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "leading to a higher basal glucose uptake rate"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   770   C1159527:glucose uptake [Cell Function]
   767   C1648294:Basal rate [Clinical Attribute]
   750   C0860803:glucose high [Finding]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0205112:Basal [Spatial Concept]
   744   C0243144:Uptake [Physiologic Function]
   744   C0332152:Leading [Temporal Concept]
   744   C0347980:% uptake [Quantitative Concept]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]
   744   C1522538:Leading [Functional Concept]
   734   C0861064:high lead [Finding]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711   C2700149:HIGH [Intellectual Product]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the insulin-sensitizing effects of the drugs"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   793   C0728866:effect of drugs [Functional Concept]
           drug effects
   748   C1280500:effects [Qualitative Concept]
   741 E C0728867:Drug effect [Pathologic Function]
   741 E C1411996:drug effect [Biologic Function]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "(9,"

Phrase: "16,"

Phrase: "33,"

Phrase: "34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.234: Very recently, Wu et al. 

Phrase: "Very recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332185:Recently [Temporal Concept]
   861   C0442824:Very [Qualitative Concept]

Phrase: "Wu et al."
Processing 00000000.tx.235: (36) reported that TZD activate GLUT4 transcription by PPAR in differentiating 3T3 fibroblasts, either alone or in combination with C/EBP and -, by a process requiring 2448 h. 

Phrase: "(36"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "GLUT4 transcription by PPAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040649:Transcription [Genetic Function]

Phrase: "in differentiating 3T3 fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "with C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108685:C/EBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and -"

Phrase: ","

Phrase: "by a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "requiring"

Phrase: "2448 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.236: We therefore conclude that the marked acute insulin-sensitizing potency of MCC-555 in cardiomyocytes involves a mechanism completely different from that of troglitazone, in agreement with our observations of a rapid concomitant modification of the insulin signaling cascade (see below) by MCC-555. 

Phrase: "We therefore"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the marked acute insulin-sensitizing potency of MCC-555"

Phrase: "in cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "involves"

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "completely different from that of troglitazone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "of a rapid concomitant modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "of the insulin signaling cascade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2611812:signaling cascade [Cell Function]
   827   C1707310:Cascade [Manufactured Object]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: "by MCC-555."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.237: Certainly, it may be anticipated that upon chronic exposure, this TZD may also enhance glucose transporter expression, and further work will be needed to explore this pathway, which could additionally contribute to the high in vivo potency of this drug. 

Phrase: "Certainly,"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "anticipated"

Phrase: "that upon chronic exposure,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205191:chronic [Temporal Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "this TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "may"

Phrase: "also"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "glucose transporter expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "further work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "will"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "this pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "which"

Phrase: "could"

Phrase: "additionally"

Phrase: "contribute to the high in vivo potency of this drug."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C1515655:In Vivo [Spatial Concept]
           vivo
   757   C0678792:drug potency [Biologic Function]
   739   C0013227:Drug [Pharmacologic Substance]
   739   C0205250:High [Qualitative Concept]
   739   C1254351:Drug [Pharmacologic Substance]
   739   C1299351:High [Qualitative Concept]
   739   C1880177:Contribute [Activity]
   739   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.238: Extensive investigations have been carried out to identify potential targets of TZD action upstream of GLUT4 at the level of the insulin signaling cascade. 

Phrase: "Extensive investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261322:Investigations [Health Care Activity]
   827 E C1552578:investigation [Idea or Concept]
   777 E C1517586:Investigational [Qualitative Concept]
   777 E C3245491:investigational [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "identify"

Phrase: "potential targets of TZD action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]

Phrase: "upstream of GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "at the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of the insulin signaling cascade."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2611812:signaling cascade [Cell Function]
   827   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.239: Thus, earlier work demonstrated that insulin receptor autophosphorylation and kinase activity could be normalized by pioglitazone treatment in fatty Zucker rats (37) and high fat-fed rats (38). 

Phrase: "Thus,"

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "demonstrated"

Phrase: "that insulin receptor autophosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0813988:autophosphorylation [Molecular Function]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "could"

Phrase: "be"

Phrase: "normalized by pioglitazone treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0039798:treatment [Functional Concept]
   770   C0071097:pioglitazone [Organic Chemical,Pharmacologic Substance]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C1882115:Normalized [Research Activity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "in fatty Zucker rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(37"

Phrase: ")"

Phrase: "and"

Phrase: "high fat-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.240: Subsequent work showed that troglitazone was able to prevent the glucose-induced desensitization of the insulin receptor kinase, possibly involving the modulation of PKC (39). 

Phrase: "Subsequent work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that troglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the glucose-induced desensitization of the insulin receptor kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1709852:Receptor Desensitization [Molecular Function]
           Desensitization
   742   C0178702:Desensitization [Therapeutic or Preventive Procedure]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the modulation of PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.241: However, any direct effect of TZD on insulin binding and receptor tyrosine kinase activity has been excluded (21). 

Phrase: "However,"

Phrase: "any direct effect of TZD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin binding"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1623517:insulin binding [Molecular Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "receptor tyrosine kinase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C1152633:receptor activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "has"

Phrase: "been"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.242: Further, the insulin-stimulated tyrosine phosphorylation of IRS-1 remained unaffected following a 5-h preincubation of Chinese hamster ovary cells with different TZD (21). 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the insulin-stimulated tyrosine phosphorylation of IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1519726:Tyrosine Phosphorylation [Molecular Function]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "remained"

Phrase: "unaffected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a 5-h preincubation of Chinese hamster ovary cells"

Phrase: "with different TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   827 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   827 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.243: In complete agreement with these findings we were unable to see any modification of insulin-regulated tyrosine phosphorylation of cardiac IR and IRS-1 in response to MCC-555. 

Phrase: "In complete agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680240:Agreement [Social Behavior]

Phrase: "with these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "any modification of insulin-regulated tyrosine phosphorylation of cardiac IR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392747:Modification [Functional Concept]
   738   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "IRS-1 in response"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   790   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   790   C1334133:INSULIN RECEPTOR [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1710236:Substrate [Manufactured Object]

Phrase: "to MCC-555."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.244: We therefore conclude that these early elements of the insulin signaling cascade do not represent primary targets of TZD action. 

Phrase: "We therefore"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "these early elements of the insulin signaling cascade"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0013879:Elements [Element, Ion, or Isotope]
   711 E C1705248:Element [Conceptual Entity]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "primary targets of TZD action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.245: Instead, we show here a marked potentiation of insulin action on IRS-1-associated PI 3-kinase activity after short term preincubation of cardiomyocytes with MCC-555, being exactly coincident with the activation of glucose transport. 

Phrase: "Instead,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "a marked potentiation of insulin action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "on IRS-1-associated PI 3-kinase activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   895   C1150623:insulin receptor activity [Molecular Function]
   891   C1145751:insulin activity [Molecular Function]
   879   C1152633:receptor activity [Molecular Function]
   849   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   834   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   807   C1150423:kinase activity [Molecular Function]
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   711   C2350410:Insulin Receptor Substrate-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "after short term preincubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0443303:Short-term [Temporal Concept]

Phrase: "of cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "with MCC-555,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "being"

Phrase: "exactly coincident with the activation of glucose transport."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205420:Coincident [Temporal Concept]
Processing 00000000.tx.246: The observed potentiation of insulin-stimulated PI 3-kinase principally agrees with earlier studies of Berger and co-workers (21, 22) using adipose tissue and myotubes; 

Phrase: "The observed potentiation of insulin-stimulated PI 3-kinase principally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "agrees with earlier studies of Berger"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0947630:studies [Laboratory Procedure]
   753   C3641827:Agree [Intellectual Product]
   719 E C0557651:Study [Manufactured Object]
   719   C1279919:Early [Temporal Concept]
   719 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(21,"

Phrase: "22"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "and"

Phrase: "myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242697:myotubes [Cell]
  1000   C1704336:Myotubes [Cell]

Phrase: ";"
Processing 00000000.tx.247: however, some specific differences need further consideration. 

Phrase: "however,"

Phrase: "some specific differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "further consideration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0518609:consideration [Finding]
Processing 00000000.tx.248: First, the effects of TZD on PI 3-kinase in L6 myotubes have not been correlated to glucose transport and were not shown to be related to the IRS-1-associated PI 3-kinase activity (21). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the effects of TZD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on PI 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in L6 myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242697:myotubes [Cell]
   861   C1704336:Myotubes [Cell]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "correlated to glucose transport"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178666:glucose transport [Cell Function]
   819   C1550030:Transport To [Idea or Concept]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1317949:Transport [Manufactured Object]
   770   C1707520:Correlated [Qualitative Concept]
   770   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "to the IRS-1-associated PI 3-kinase activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   895   C1150623:insulin receptor activity [Molecular Function]
   891   C1145751:insulin activity [Molecular Function]
   879   C1152633:receptor activity [Molecular Function]
   849   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   834   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   807   C1150423:kinase activity [Molecular Function]
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   711   C2350410:Insulin Receptor Substrate-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.249: Second, in Chinese hamster ovary cells, the TZD increased the amount of p85 subunit of PI 3-kinase in antiphosphotyrosine immunoprecipitates after stimulation with insulin. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "in Chinese hamster ovary cells,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "the TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of p85 subunit of PI 3-kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "in antiphosphotyrosine"

Phrase: "immunoprecipitates after stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0301871:Immunoprecipitate [Immunologic Factor]
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.250: This differs from our findings showing an unaltered abundance of p85 in IRS-1 immunoprecipitates in response to MCC-555 and insulin. 

Phrase: "This"

Phrase: "differs from our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an unaltered abundance of p85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346714:Abundance [Qualitative Concept]

Phrase: "in IRS-1 immunoprecipitates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0301871:Immunoprecipitate [Immunologic Factor]
   771   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.251: It should also be noted that the effects of pioglitazone on insulin-stimulated PI 3-kinase activity could not be confirmed in 3T3-L1 adipocytes using both acute and long term protocols (23). 

Phrase: "It"

Phrase: "should"

Phrase: "also"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the effects of pioglitazone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin-stimulated PI 3-kinase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   895   C1145751:insulin activity [Molecular Function]
   867   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   827   C1150423:kinase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "confirmed in 3T3-L1 adipocytes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0206131:Adipocytes [Cell]
   760   C0441918:L1 [Finding]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both acute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205178:acute [Temporal Concept]

Phrase: "and"

Phrase: "long term protocols"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0442711:Protocols [Intellectual Product]
   793 E C1507394:Protocol [Intellectual Product]
   793 E C1522729:Protocol [Intellectual Product]
   793 E C2348563:Protocol [Intellectual Product]
   734   C0443252:Long-term [Temporal Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.252: Therefore, it remains to be elucidated whether PI 3-kinase represents a general target for all TZD or if certain structural requirements are implicated in the modulation of this key enzyme of insulin signaling. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated"

Phrase: "whether"

Phrase: "PI 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a general target for all TZD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "or"

Phrase: "if"

Phrase: "certain structural requirements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1514873:Requirement [Functional Concept]

Phrase: "are"

Phrase: "implicated in the modulation of this key enzyme of insulin signaling."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0037083:Signaling [Cell Function]
   738   C0443264:Modulation [Spatial Concept]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
   738   C3537152:signaling [Biologic Function]
Processing 00000000.tx.253: At least for MCC-555 we would like to conclude that the drug increases the intrinsic activity of IRS-1-associated PI 3-kinase, most likely explaining the sensitization of insulin-stimulated glucose transport. 

Phrase: "At least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "for MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "we"

Phrase: "would like to"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the intrinsic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205102:Intrinsic [Spatial Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0439674:Intrinsic [Functional Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "of IRS-1-associated PI 3-kinase,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   835   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   807 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   725   C2350410:Insulin Receptor Substrate-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "most likely explaining"

Phrase: "the sensitization of insulin-stimulated glucose transport."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1325847:Sensitisation [Mental Process]
Processing 00000000.tx.254: Changes in the intrinsic activity of PI 3-kinase are consistent with the unaltered tyrosine phosphorylation of IRS-1 and could involve the Ser phosphorylation of p85 by PI 3-kinase, a process known to inhibit the enzyme activity (40), or the Ser-phosphorylation of PI 3-kinase docking proteins such as IRS-1. 

Phrase: "Changes in the intrinsic activity of PI 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "consistent with the unaltered tyrosine phosphorylation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "could"

Phrase: "involve"

Phrase: "the Ser phosphorylation of p85"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "by PI 3-kinase,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "the Ser-phosphorylation of PI 3-kinase docking proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1753032:phosphatidylinositol phosphorylation [Molecular Function]
   745   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]

Phrase: "such as IRS-1."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.255: Initial evidence to support this view stems from our observation that MCC-555 was indeed able to promote Ser/Thr dephosphorylation of IRS-1 in cardiac cells from obese rats (see below). 

Phrase: "Initial evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "stems from our observation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0242767:Stem [Plant]
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1186763:Stem [Body Part, Organ, or Organ Component]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "indeed able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Ser/Thr dephosphorylation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1158884:Dephosphorylation [Molecular Function]
   744   C3160734:Dephosphorylation [Molecular Function]

Phrase: "in cardiac cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0920751:cardiac cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "from obese rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.256: Further work will be needed to clarify the precise molecular steps of PI 3-kinase modulation by this compound. 

Phrase: "Further work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "will"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the precise molecular steps of PI 3-kinase modulation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C1261552:steps [Conceptual Entity]
   708 E C1704379:Step [Functional Concept]
   708 E C1705117:Step [Quantitative Concept]
   708 E C2825408:Step [Manufactured Object]

Phrase: "by this compound."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]
Processing 00000000.tx.257: A member of the PPAR family of nuclear receptors, PPAR, has been implicated in the control of adipocyte differentiation and expression of fat-specific genes (17) and must be considered as the major target for intracellular action of TZD (1, 2, 14, 15, 32). 

Phrase: "A member of the PPAR family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "of nuclear receptors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206588:Receptors, Nuclear [Amino Acid, Peptide, or Protein,Receptor]
   861   C0521447:Nuclear [Spatial Concept]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "PPAR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   982   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   982   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the control of adipocyte differentiation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C1159884:adipocyte differentiation [Cell Function]
   748   C0007589:Differentiation [Cell Function]
   748   C0206131:Adipocyte [Cell]
   748   C0243148:control [Qualitative Concept]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2945687:Differentiation [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "expression of fat-specific genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "must"

Phrase: "be"

Phrase: "considered as the major target"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205164:Major [Qualitative Concept]
   760   C0750591:considered [Idea or Concept]
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "for intracellular action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441472:Action [Functional Concept]
   861   C3266814:Action [Activity]

Phrase: "of TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "14,"

Phrase: "15,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.258: Expression of PPAR2 appears to be restricted to adipose tissue (41), whereas PPAR1 is found in various tissues, including heart and skeletal muscle in both rodents (42, 43) and humans (30, 41), albeit at a much lower level. 

Phrase: "Expression of PPAR2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "restricted to adipose tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0001527:Adipose tissue [Tissue]
   770   C0040300:Tissue [Tissue]
   770   C0443288:Restricted [Functional Concept]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "(41"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "PPAR1"

Phrase: "is"

Phrase: "found in various tissues,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0040300:Tissues [Tissue]
   770   C0150312:Found [Quantitative Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   737 E C0243095:Find [Finding]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "skeletal muscle in both rodents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0242692:Muscle, Skeletal [Tissue]
   806   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   760   C0026845:Muscle [Tissue]
   760   C0037253:skeletal [Body System]
   760   C0521324:Skeletal [Spatial Concept]

Phrase: "(42,"

Phrase: "43"

Phrase: ")"

Phrase: "and"

Phrase: "humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "(30,"

Phrase: "41"

Phrase: ")"

Phrase: ","

Phrase: "albeit at a much lower level."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0441889:Level [Qualitative Concept]
   753   C0441994:Lower [Spatial Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]
   753   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.259: Using RT-PCR, Auboeuf et al. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "Auboeuf et al."
Processing 00000000.tx.260: (41) reported that PPAR in skeletal muscle amounts to only 34% of the expression seen in fat. 

Phrase: "(41"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that PPAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   982   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   982   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "to only 34% of the expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205171:Only [Quantitative Concept]
   753   C1720467:Only [Intellectual Product]
   753   C1883351:To [Qualitative Concept]

Phrase: "seen in fat."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C0424612:FAT [Organism Attribute]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.261: Interestingly, at least in rodents a considerably higher PPAR expression has been reported for cardiac muscle (3- to 5-fold higher; estimated from Fig. 1 of Ref. 41) compared with skeletal muscle (42, 44). 

Phrase: "Interestingly,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in rodents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodents [Mammal]

Phrase: "a considerably higher PPAR expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0597360:receptor expression [Genetic Function]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "reported for cardiac muscle"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0027061:Muscle, Cardiac [Tissue]
   770   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   770   C0026845:Muscle [Tissue]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1522601:Cardiac [Spatial Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 5-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: ";"

Phrase: "estimated from Fig. 1 of Ref. 41"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   774   C1332102:REF-1 [Gene or Genome]
   748   C0349966:Fig [Food]
   748   C0750572:Estimated [Quantitative Concept]
   748   C1337208:FIG [Food]
   748   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "compared with skeletal muscle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0242692:Muscle, Skeletal [Tissue]
   833   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   770   C0026845:Muscle [Tissue]
   770   C0037253:skeletal [Body System]
   770   C0521324:Skeletal [Spatial Concept]
   770   C1707455:Compared [Activity]

Phrase: "(42,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.262: In the present investigation we have determined the protein expression of PPAR in our cardiomyocyte preparation and found it to be 2030% of that in adipocytes, in excellent agreement with the above-mentioned investigations. 

Phrase: "In the present investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "determined"

Phrase: "the protein expression of PPAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1171362:protein expression [Genetic Function]
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in our cardiomyocyte preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "2030% of that"

Phrase: "in adipocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "in excellent agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680240:Agreement [Social Behavior]

Phrase: "with the above-mentioned investigations."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261322:Investigations [Health Care Activity]
   793 E C1552578:investigation [Idea or Concept]
   743 E C1517586:Investigational [Qualitative Concept]
   743 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.263: This observation strongly suggests that the induction of glucose transporter expression by long term treatment of cardiomyocytes with troglitazone, as reported in our earlier study (9), results from activation of the cardiac PPAR receptor. 

Phrase: "This observation strongly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the induction of glucose transporter expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by long term treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023977:long-term treatment [Health Care Activity]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0443252:Long-term [Temporal Concept]

Phrase: "of cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "with troglitazone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "reported in our earlier"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737   C1279919:Early [Temporal Concept]
   737 E C3273238:Report [Intellectual Product]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "results from activation of the cardiac PPAR receptor."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   779   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   779   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   754   C1514758:Receptor Activation [Cell Function]
   738   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C1274040:Result [Functional Concept]
   738   C1522601:Cardiac [Spatial Concept]
   738   C1546471:Result [Idea or Concept]
   738   C1879547:Activated [Activity]
           Activation
   738   C2825142:Result [Finding]
   738   C3546463:peroxisomal [Cell Component]
   720   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   704 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.264: Most interestingly, we show here that inhibition of protein synthesis completely eliminates the rapid effects of MCC-555 on insulin signaling. 

Phrase: "Most interestingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that inhibition of protein synthesis completely"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1519619:Protein Synthesis Inhibition [Genetic Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "eliminates"

Phrase: "the rapid effects of MCC-555"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.265: Based on available binding data it is reasonable to assume that the action of MCC-555 involves the PPAR receptor (31). 

Phrase: "Based on available binding data"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   781   C0242356:data base [Intellectual Product]
   781   C0993637:Data Base [Intellectual Product]
   760   C0243122:binding [Functional Concept]
   760   C0470187:Available [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1511726:Data [Idea or Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C3245479:data [Medical Device]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "it"

Phrase: "is"

Phrase: "reasonable to"

Phrase: "assume"

Phrase: "that"

Phrase: "the action of MCC-555"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "involves"

Phrase: "the PPAR receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.266: The novel properties of MCC-555 with respect to PPAR activation (31) may at least partly explain the differential response of cardiomyocytes observed with this TZD and troglitazone (9). 

Phrase: "The novel properties of MCC-555"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "with respect to PPAR activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1514758:Receptor Activation [Cell Function]
   804   C1879547:Activation [Activity]
   753   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "may at least partly"

Phrase: "explain"

Phrase: "the differential response of cardiomyocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "observed with this TZD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   770   C1441672:Observed [Functional Concept]
   737 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   737 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "and"

Phrase: "troglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.267: Given the observation that MCC-555 enhances the intrinsic PI 3-kinase activity (see above), it is tempting to speculate that this drug controls the synthesis of a PI 3-kinase modulator protein. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the intrinsic PI 3-kinase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   888   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that"

Phrase: "this drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the synthesis of a PI 3-kinase modulator protein."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   762   C0597295:Protein Synthesis [Molecular Function]
   762   C1157394:phosphatidylinositol synthesis [Molecular Function]
   742   C0220781:synthesis [Biologic Function]
   742   C1883254:Synthesis [Activity]
   726 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.268: Such a hypothetical protein could be a PI 3-kinase activator, a phosphatase, phosphatase activator (see discussion below), or a kinase inhibitor. 

Phrase: "Such"

Phrase: "a hypothetical protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "be"

Phrase: "a PI 3-kinase activator,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C2247123:kinase activator [Molecular Function]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a phosphatase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1149880:phosphatase [Molecular Function]

Phrase: "phosphatase activator"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "discussion below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0557061:Discussion [Therapeutic or Preventive Procedure]
   833   C2584313:Discussion [Social Behavior]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "a kinase inhibitor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   901   C3537023:kinase inhibitor [Molecular Function]
   901   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.269: Identification of this protein and the elucidation of its physiological regulation might represent a major goal for future work. 

Phrase: "Identification of this protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "the elucidation of its physiological regulation"

Phrase: "might"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a major goal for future work."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018017:Goal [Intellectual Product]
   753   C1571704:Goal [Idea or Concept]
Processing 00000000.tx.270: In a recent report from this laboratory we showed that cardiac insulin resistance of obesity correlates to a reduced sensitivity of glucose transport, probably resulting from a defective activation of PI 3-kinase (20). 

Phrase: "In a recent report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "from this laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that cardiac insulin resistance of obesity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "correlates to a reduced sensitivity of glucose transport,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0178666:glucose transport [Cell Function]
   767   C1550030:Transport To [Idea or Concept]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0036667:Sensitivity [Quantitative Concept]
   744   C0312418:Sensitivity [Mental Process]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0427965:Sensitivity [Finding]
   744   C1317949:Transport [Manufactured Object]
   744   C1511883:Sensitivity [Quantitative Concept]
   744   C1522640:Sensitivity [Qualitative Concept]
   744   C2346484:SENSITIVITY [Phenomenon or Process]
   744   C2349185:Sensitivity [Qualitative Concept]
   744   C3495449:transport [Medical Device]
   731   C0332324:Sensitive to [Functional Concept]

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "resulting from a defective activation of PI 3-kinase"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   790   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   762 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0332452:Defective [Functional Concept]
   742   C0678226:resulting [Functional Concept]
   742   C1879547:Activation [Activity]
   742   C2348046:Phosphatidylinositol [Lipid]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.271: We show here that a short preincubation of cardiomyocytes from obese Zucker rats with MCC-555 completely ameliorates the insulin resistance, leading to a normal half-maximal and increased maximal insulin response of glucose transport. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that"

Phrase: "a short preincubation of cardiomyocytes"

Phrase: "from obese Zucker rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "with MCC-555 completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   827   C0205197:Completely [Qualitative Concept]

Phrase: "ameliorates"

Phrase: "the insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "leading to a normal half-maximal"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   753   C0205289:Maximal [Qualitative Concept]
   753   C0205307:Normal [Qualitative Concept]
   753   C0332152:Leading [Temporal Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C0806909:Maximal [Quantitative Concept]
   753   C1522538:Leading [Functional Concept]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2825407:Half [Quantitative Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "increased maximal insulin response of glucose transport."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]
Processing 00000000.tx.272: These data suggest that the mechanisms of PI 3-kinase modulation by MCC-555, as discussed above, also operate in an insulin-resistant cell and enable the drug to correct the defect in insulin action. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mechanisms of PI 3-kinase modulation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "by MCC-555,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "discussed above,"

Phrase: "also"

Phrase: "operate in an insulin-resistant cell"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0030281:Insulin Cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0332325:Resistant [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2827757:RESISTANT [Laboratory or Test Result]
   753   C3242339:operate [Functional Concept]

Phrase: "and"

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "the drug to correct"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0013227:Drug [Pharmacologic Substance]
   770   C1254351:Drug [Pharmacologic Substance]
   715 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   715 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]

Phrase: "the defect in insulin action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.273: Correction of insulin signaling defects in fatty Zucker rats has also been reported for pioglitazone under in vivo conditions (45). 

Phrase: "Correction of insulin signaling defects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705565:CORRECTION [Intellectual Product]
   760   C1947976:Correction [Functional Concept]

Phrase: "in fatty Zucker rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported for pioglitazone"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0071097:pioglitazone [Organic Chemical,Pharmacologic Substance]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "under in vivo conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   734   C1515655:In Vivo [Spatial Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.274: However, this failed to normalize the defect in glucose transport and glucose transporter translocation (46), suggesting that this TZD does not modify the specific elements of insulin signaling leading to GLUT4 translocation (23). 

Phrase: "However,"

Phrase: "this failed to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0231175:Failed [Functional Concept]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "the defect in glucose transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0342750:Glucose transport defect [Disease or Syndrome]
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "glucose transporter translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]
   734   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the specific elements of insulin signaling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0013879:Elements [Element, Ion, or Isotope]
   719 E C1705248:Element [Conceptual Entity]

Phrase: "leading to GLUT4 translocation"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332152:Leading [Temporal Concept]
   770   C1420175:GLUT4 [Gene or Genome]
   770   C1522538:Leading [Functional Concept]
   770   C2982484:GLUT4 [Gene or Genome]
   770   C2987521:Translocation [Activity]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.275: Cardiac insulin resistance of insulin signaling was paralleled by a hyperphosphorylation of IRS-1 on Ser/Thr, which is known to function as a negative control mechanism (20). 

Phrase: "Cardiac insulin resistance of insulin signaling"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "was"

Phrase: "paralleled by a hyperphosphorylation of IRS-1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   764   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   764   C1334133:INSULIN RECEPTOR [Gene or Genome]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1710236:Substrate [Manufactured Object]
   708   C2348042:Parallel [Qualitative Concept]
   708   C2826345:PARALLEL [Research Activity]

Phrase: "on Ser/Thr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "function as a negative control mechanism"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   790   C1639518:% negative control [Quantitative Concept]
   790   C1947986:Negative Control [Conceptual Entity]
   783   C2587213:Control function [Functional Concept]
           Control
   753   C0031843:function [Physiologic Function]
   753   C0205160:Negative [Qualitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C0441712:Mechanism [Functional Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1513916:Negative [Finding]
   753   C1550141:Control [Substance]
   753   C1705273:Function [Intellectual Product]
   753   C1706376:Mechanism [Manufactured Object]
   753   C1882979:Control [Conceptual Entity]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.276: This hyperphosphorylation was largely reduced in the presence of MCC-555. 

Phrase: "This hyperphosphorylation"

Phrase: "was"

Phrase: "largely"

Phrase: "reduced in the presence of MCC-555."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.277: It may be speculated that this dephosphorylation is linked to the normalization of PI 3-kinase and glucose transport activation, although direct evidence for this relationship is still missing. 

Phrase: "It"

Phrase: "may"

Phrase: "be"

Phrase: "speculated"

Phrase: "that"

Phrase: "this dephosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158884:Dephosphorylation [Molecular Function]
  1000   C3160734:Dephosphorylation [Molecular Function]

Phrase: "is"

Phrase: "linked to the normalization of PI 3-kinase"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   800   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1882115:Normalization [Research Activity]
   744   C2348046:Phosphatidylinositol [Lipid]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "glucose transport activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1879547:Activation [Activity]
   734   C0178666:glucose transport [Cell Function]

Phrase: "although"

Phrase: "direct evidence for this relationship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "still missing."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C1551393:Missing [Idea or Concept]
   861   C1705492:Missing [Qualitative Concept]
   861   C3272743:MISSING [Qualitative Concept]
   827 E C2349206:Miss [Conceptual Entity]
Processing 00000000.tx.278: Tumor necrosis factor- is also known to induce insulin resistance by serine phosphorylation of IRS-1 in adipocytes (47). 

Phrase: "Tumor necrosis factor-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "is"

Phrase: "also"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "insulin resistance by serine phosphorylation of IRS-1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   799   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   760   C0021655:Insulin Resistance [Pathologic Function]
   760   C2700570:INSULIN RESISTANCE [Gene or Genome]
   757   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   757   C1334133:INSULIN RECEPTOR [Gene or Genome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0237834:Resistance [Mental Process]
   739   C1514892:Resistance [Physiologic Function]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.279: As recently shown by Peraldi et al. 

Phrase: "As"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown by Peraldi et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.280: (48), the effect of tumor necrosis factor- on insulin signaling can be essentially blocked by TZD, supporting our view that dephosphorylation of critical proteins on Ser/Thr may be a major step in the molecular pathways of TZD action. 

Phrase: "(48"

Phrase: ")"

Phrase: ","

Phrase: "the effect of tumor necrosis factor-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "can"

Phrase: "be"

Phrase: "essentially"

Phrase: "blocked by TZD,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   790   C2983591:BLOCKED [Research Activity]
   756 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]
   756 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "our"

Phrase: "view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that dephosphorylation of critical proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1158884:Protein dephosphorylation [Molecular Function]
           Dephosphorylation
   760   C3160734:Dephosphorylation [Molecular Function]

Phrase: "on Ser/Thr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "a major step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "the molecular pathways of TZD action."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1704259:molecular pathway [Molecular Function]
           Pathways
   753   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.281: In summary, MCC-555 is a highly potent new TZD that is able to potentiate insulin signaling by increasing the intrinsic activity of IRS-1-associated PI 3-kinase, leading to enhanced glucose transport in normal and insulin-resistant cardiomyocytes. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "a highly potent new TZD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   779 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   779 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "potentiate"

Phrase: "insulin signaling by increasing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037083:Signaling [Cell Function]
   770   C3537152:signaling [Biologic Function]

Phrase: "the intrinsic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205102:Intrinsic [Spatial Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0439674:Intrinsic [Functional Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "of IRS-1-associated PI 3-kinase,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   835   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   807 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   725   C2350410:Insulin Receptor Substrate-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "leading to enhanced glucose transport"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0178666:glucose transport [Cell Function]
   797   C1550030:Transport To [Idea or Concept]
   760   C0005528:Transport, NOS [Cell Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0332152:Leading [Temporal Concept]
   760   C1317949:Transport [Manufactured Object]
   760   C1522538:Leading [Functional Concept]
   760   C2349975:Enhanced [Activity]
   760   C3495449:transport [Medical Device]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "insulin-resistant cardiomyocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0225828:Cardiomyocytes [Cell]
Processing 00000000.tx.282: This drug effect is dependent on protein synthesis and may involve the dephosphorylation of signaling intermediates such as IRS-1. 

Phrase: "This drug effect"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0728866:Drug effect [Functional Concept]
  1000   C0728867:Drug effect [Pathologic Function]
  1000   C1411996:drug effect [Biologic Function]
   861   C0013227:Drug [Pharmacologic Substance]
   861   C1254351:Drug [Pharmacologic Substance]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "is"

Phrase: "dependent on protein synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "involve"

Phrase: "the dephosphorylation of signaling intermediates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1158884:Dephosphorylation [Molecular Function]
   760   C3160734:Dephosphorylation [Molecular Function]

Phrase: "such as IRS-1."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.283: It is suggested that MCC-555 provides a causal therapy of insulin resistance by targeted action on the defective site.  

Phrase: "It"

Phrase: "is"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that MCC-555"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a causal therapy of insulin resistance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0039798:therapy [Functional Concept]
   753   C0087111:Therapy [Therapeutic or Preventive Procedure]
   753   C1363945:Therapy [Finding]

Phrase: "by targeted action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441472:Action [Functional Concept]
   861   C3266814:Action [Activity]

Phrase: "on the defective site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.284: Footnotes  1 This work was supported by the Ministerium fr Wissenschaft und Forschung des Landes Nordrhein-Westfalen, the Bundesministerium fr Gesundheit, EU COST Action B5, and a grant from Mitsubishi Chemical (Yokohama, Japan). 

Phrase: "Footnotes  1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Ministerium fr Wissenschaft und Forschung des Landes Nordrhein-Westfalen,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   736   C1413574:UND [Gene or Genome]
   736   C1521721:Supported [Conceptual Entity]
   736   C2348513:Fr. [Conceptual Entity]
   736   C3538902:FR [Gene or Genome]
   703 E C0183683:Support [Medical Device]

Phrase: "the Bundesministerium fr Gesundheit,"

Phrase: "EU COST Action B5,"

Phrase: "and"

Phrase: "a grant from Mitsubishi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018173:Grant [Quantitative Concept]
   770   C1548284:Grant [Idea or Concept]

Phrase: "Chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]

Phrase: "(Yokohama,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.285: Received March 18, 1998.  

Phrase: "Received March 18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1998."
Processing 00000000.tx.286: References Top Abstract Introduction Materials and Methods Results Discussion References  Whitcomb RW, Saltiel AR 1995 Thiazolidinediones. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Whitcomb RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "Saltiel AR 1995 Thiazolidinediones."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   779 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   779 E C3537039:Thiazolidinedione [Pharmacologic Substance]
Processing 00000000.tx.287: Exp Opin Invest Drugs 4:12991309 Saltiel AR, Olefsky JM 1996 Thiazolidinediones in the treatment of insulin resistance and type II diabetes. 

Phrase: "Exp Opin"

Phrase: "Invest"

Phrase: "Drugs 4"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: ":"

Phrase: "12991309 Saltiel AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2986463:AR+ [Finding]

Phrase: "Olefsky JM 1996 Thiazolidinediones in the treatment of insulin resistance"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   706 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   706 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "and"

Phrase: "type II diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type II [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.288: Diabetes 45:16611669[Abstract] Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H 1988 Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "16611669"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fujiwara T,"

Phrase: "Yoshioka S,"

Phrase: "Yoshioka T,"

Phrase: "Ushiyama I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Horikoshi H 1988 Characterization of new oral antidiabetic agent CS-045"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1880022:Characterization [Activity]

Phrase: ":"

Phrase: "studies in KK"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "ob/ob mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "Zucker fatty rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.289: Diabetes 37:15491558[Abstract] Stevenson RW, Hutson NJ, Krupp MN, Volkmann RA, Holland GF, Eggler JF, Clark DA, McPherson RK, Hell XL, Danbury BH 1990 Actions of a novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice. 

Phrase: "Diabetes 37"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "15491558"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Stevenson RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "Hutson NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Krupp MN,"

Phrase: "Volkmann RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Holland GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Eggler JF,"

Phrase: "Clark DA,"

Phrase: "McPherson RK,"

Phrase: "Hell XL,"

Phrase: "Danbury BH 1990 Actions of a novel antidiabetic agent englitazone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0441472:actions [Functional Concept]
   706 E C3266814:Action [Activity]

Phrase: "in hyperglycemic hyperinsulinemic ob/ob mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0162418:Hyperglycemic Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.290: Diabetes 39:12181227[Abstract] Lee M-K, Miles PDG, Khoursheed M, Gao K-M, Moossa AR, Olefsky JM 1994 Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. 

Phrase: "Diabetes 39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "12181227"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lee"

Phrase: "M-"

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Miles PDG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418531:PDG [Gene or Genome]
   861   C3274756:PDG [Gene or Genome]

Phrase: "Khoursheed M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gao K-M,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Moossa AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "Olefsky JM 1994 Metabolic effects of troglitazone"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C2945675:metabolic effects [Physiologic Function]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on fructose-induced insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   861   C0021655:Insulin Resistance [Pathologic Function]
   861   C2700570:INSULIN RESISTANCE [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0237834:Resistance [Mental Process]
   812   C1514892:Resistance [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   741 E C0332325:Resistant [Functional Concept]
   741 E C1550464:resistent [Idea or Concept]
   741 E C2827757:RESISTANT [Laboratory or Test Result]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.291: Diabetes 43:14351439[Abstract] Bowen L, Steven PP, Stevenson R, Shulman CI 1991 The effect of CP-68772, a thiazolidine derivative, on insulin sensitivity in lean and obese Zucker rats. 

Phrase: "Diabetes 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "14351439"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bowen L,"

Phrase: "Steven PP,"

Phrase: "Stevenson R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Shulman CI 1991"

Phrase: "The effect of CP-68772,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "a thiazolidine derivative,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527240:Derivative [Functional Concept]

Phrase: "on insulin sensitivity"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in lean"

Phrase: "and"

Phrase: "obese Zucker rats."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.292: Metabolism 40:10251030[Medline] Oakes ND, Kennedy CJ, Jenkins AB, Laybulf DR, Chisholm DJ, Kraegen EW 1994 A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. 

Phrase: "Metabolism 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "10251030"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Oakes ND,"

Phrase: "Kennedy CJ,"

Phrase: "Jenkins AB,"

Phrase: "Laybulf DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Chisholm DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Kraegen EW 1994"

Phrase: "A new antidiabetic agent,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0935929:Anti-diabetic Agent [Pharmacologic Substance]
           antidiabetic
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "BRL 49653,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0289314:BRL 49653 [Organic Chemical,Pharmacologic Substance]
   861   C1412820:BRL [Gene or Genome]

Phrase: "reduces"

Phrase: "lipid availability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Availability [Functional Concept]

Phrase: "and"

Phrase: "improves"

Phrase: "insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucoregulation in the rat."
Processing 00000000.tx.293: Diabetes 43:12031210[Abstract] Young PW, Cawthorne MA, Coyle PJ, Holder JC, Holman GD, Kozka IJ, Kirkham DM, Lister CA, Smith SA 1995 Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. 

Phrase: "Diabetes 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "12031210"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Young PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Cawthorne MA,"

Phrase: "Coyle PJ,"

Phrase: "Holder JC,"

Phrase: "Holman GD,"

Phrase: "Kozka IJ,"

Phrase: "Kirkham DM,"

Phrase: "Lister CA,"

Phrase: "Smith SA 1995 Repeat treatment of obese mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "with BRL 49653,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0289314:BRL 49653 [Organic Chemical,Pharmacologic Substance]
   861   C1412820:BRL [Gene or Genome]

Phrase: "a new potent insulin sensitizer,"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "insulin action in white adipocytes."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0441472:Action [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3266814:Action [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.294: Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. 

Phrase: "Association with increased insulin binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "cell-surface GLUT4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420175:GLUT4 [Gene or Genome]
   827   C2982484:GLUT4 [Gene or Genome]
   734   C0699040:Cell surface [Cell Component]

Phrase: "as"

Phrase: "measured by photoaffinity labeling."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0444706:Measured [Qualitative Concept]
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.295: Diabetes 44:10871092[Abstract] Bhr M, Spelleken M, Bock M, von Holtey M, Kiehn R, Eckel J 1996 Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes. 

Phrase: "Diabetes 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "10871092"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bhr M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Spelleken M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bock M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "von Holtey M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Kiehn R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Eckel J 1996 Acute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205178:acute [Temporal Concept]

Phrase: "and"

Phrase: "chronic effects of troglitazone"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205191:chronic [Temporal Concept]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "(CS-045"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056565:CS 045 [Organic Chemical,Pharmacologic Substance]
   861   C3540510:cs [Quantitative Concept]

Phrase: ")"

Phrase: "on isolated rat ventricular cardiomyocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0225828:Cardiomyocytes [Cell]
Processing 00000000.tx.296: Diabetologia 39:766774[CrossRef][Medline] Ciaraldi TP, Gilmore A, Olefsky JM, Goldberg M, Heidenreich KA 1990 In vitro studies on the action of CS-045, a new antidiabetic agent. 

Phrase: "Diabetologia 39"

Phrase: ":"

Phrase: "766774"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ciaraldi TP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]

Phrase: "Gilmore A,"

Phrase: "Olefsky JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Goldberg M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Heidenreich KA 1990 In vitro studies on the action of CS-045,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   754   C0681828:in vitro study [Research Activity]
           studies vitro
   736   C0947630:studies [Laboratory Procedure]
   734   C2986485:Action Study [Research Activity]
   703 E C0557651:Study [Manufactured Object]
   703 E C2603343:Study [Research Activity]

Phrase: "a new antidiabetic agent."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0935929:Anti-diabetic Agent [Pharmacologic Substance]
           antidiabetic
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.297: Metabolism 39:10561062[Medline] Nolan JJ, Ludvik B, Beerdsen P, Joyce, Olefsky J 1994 Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. 

Phrase: "Metabolism 39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "10561062"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nolan JJ,"

Phrase: "Ludvik B,"

Phrase: "Beerdsen P,"

Phrase: "Joyce,"

Phrase: "Olefsky J 1994 Improvement in glucose tolerance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986411:Improvement [Conceptual Entity]

Phrase: "and"

Phrase: "insulin resistance in obese subjects"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "treated with troglitazone."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.298: N Engl J Med 331:11881193[Abstract/Free FullText] Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS 1997 Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. 

Phrase: "N Engl J Med 331"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "11881193"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ehrmann DA,"

Phrase: "Schneider DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Sobel"

Phrase: "BE"

Phrase: ","

Phrase: "Cavaghan MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Imperial J,"

Phrase: "Rosenfield RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Polonsky KS 1997 Troglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "improves"

Phrase: "defects in insulin action,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0243067:defects [Functional Concept]
   737 E C1457869:Defect [Functional Concept]
   737 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "ovarian steroidogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597513:steroidogenesis [Molecular Function]

Phrase: "and"

Phrase: "fibrinolysis in women"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0016017:Fibrinolysis [Physiologic Function]
   790   C1305868:Fibrinolysis [Laboratory Procedure]
   718 E C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]

Phrase: "with polycystic ovary syndrome."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032460:Polycystic Ovary Syndrome [Disease or Syndrome]
           Polycystic ovary
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0039082:Syndrome [Disease or Syndrome]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]
   827   C3273362:Polycystic [Qualitative Concept]
Processing 00000000.tx.299: J Clin Endocrinol Metab 82:21082116[Abstract/Free FullText] Izumino K, Sakamaki H, Ishibashi M, Takino H, Yamasaki H, Yamaguchi Y, Chikuba N, Matsumoto K, Akazawa S, Tokuyama K, Nagataki S 1997 Troglitazone ameliorates insulin resistance in patients with Werners syndrome. 

Phrase: "J Clin Endocrinol Metab 82"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "21082116"

Phrase: "[Abstract/Free FullText"

Phrase: "] Izumino K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sakamaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ishibashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Takino H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yamasaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yamaguchi Y,"

Phrase: "Chikuba N,"

Phrase: "Matsumoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Akazawa S,"

Phrase: "Tokuyama K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nagataki S 1997 Troglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "ameliorates"

Phrase: "insulin resistance in patients"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with Werners syndrome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043119:Werners Syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.300: J Clin Endocrinol Metab 82:23912395[Abstract/Free FullText] Lehman JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisomal proliferator-activated receptor gamma. 

Phrase: "J Clin Endocrinol Metab 82"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "23912395"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lehman JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Moore LB,"

Phrase: "Smith-Oliver TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1506978:Ta [Immunologic Factor]
   827   C1705538:TA [Idea or Concept]

Phrase: "Wilkison WO,"

Phrase: "Willson TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Kliewer SA 1995"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0036243:SA [Geographic Area]
   827   C1539696:SA [Gene or Genome]
   827   C1825840:SA [Gene or Genome]
   827   C3539736:Sa [Spatial Concept]

Phrase: "An antidiabetic thiazolidinedione"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   861   C1257987:Thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   861   C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "is"

Phrase: "a high affinity ligand for peroxisomal proliferator-activated receptor gamma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   775   C0683185:receptor ligand affinity [Molecular Function]
   757   C1621296:receptor ligand [Molecular Function]
   739   C0023688:Ligand [Chemical]
Processing 00000000.tx.301: J Biol Chem 270:1295312956[Abstract/Free FullText] Berger J, Bailey P, Biswas C, Cullinan CA, Doebber TW, Hayes NS, Saperstein R, Smith RG, Leibowitz MD 1996 Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-: binding and activation correlate with antidiabetic action in db/db mice. 

Phrase: "J Biol Chem 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1295312956"

Phrase: "[Abstract/Free FullText"

Phrase: "] Berger J,"

Phrase: "Bailey P,"

Phrase: "Biswas C,"

Phrase: "Cullinan CA,"

Phrase: "Doebber TW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039260:TW [Geographic Area]
   861   C0332293:TW [Therapeutic or Preventive Procedure]

Phrase: "Hayes NS,"

Phrase: "Saperstein R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Smith RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Leibowitz MD 1996 Thiazolidinediones"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   779 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   779 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "produce"

Phrase: "a conformational change in peroxisomal proliferator-activated receptor-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0301641:Conformational change [Molecular Function]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: ":"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "correlate with antidiabetic action"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441472:Action [Functional Concept]
   770   C0935929:antidiabetic [Pharmacologic Substance]
   770   C3266814:Action [Activity]

Phrase: "in db/db mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.302: Endocrinology 137:41894195[Abstract] Kletzien RF, Clark SD, Ulrich RG 1992 Enhancement of adipocyte differentiation by an insulin-sensitizing agent. 

Phrase: "Endocrinology 137"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "41894195"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kletzien RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Clark SD,"

Phrase: "Ulrich RG 1992 Enhancement of adipocyte differentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   748   C2349975:Enhancement [Activity]

Phrase: "by an insulin-sensitizing agent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.303: Mol Pharmacol 41:393398[Abstract] Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPAR2, a lipid activated transcription factor. 

Phrase: "Mol Pharmacol 41"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "393398"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tontonoz P,"

Phrase: "Hu E,"

Phrase: "Spiegelman BM 1994 Stimulation of adipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "by PPAR2,"

Phrase: "a lipid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipid [Lipid]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "transcription factor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.304: Cell 79:11471156[Medline] Schmitz-Pfeiffer C, Oakes ND, Browne CL, Kraegen EW, Biden TJ 1997 Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653. 

Phrase: "Cell 79"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "11471156"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schmitz-Pfeiffer C,"

Phrase: "Oakes ND,"

Phrase: "Browne CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Kraegen EW,"

Phrase: "Biden TJ 1997 Reversal of chronic alterations of skeletal muscle protein kinase C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0443290:Reversal [Functional Concept]

Phrase: "from fat-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "by BRL-49653."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0289314:BRL 49653 [Organic Chemical,Pharmacologic Substance]
   861   C1412820:BRL [Gene or Genome]
Processing 00000000.tx.305: Am J Physiol 273:E915E921 Eckel J, Mller H, Niggemann J, Fujiwara T, Horikoshi H, Kiehn R 1997 Troglitazone-induced insulin sensitizing in cardiac muscle of diabetic ZDF-rats correlates to inhibition and redistribution of membrane-asssociated PKC. 

Phrase: "Am"

Phrase: "J Physiol 273"

Phrase: ":"

Phrase: "E915E921 Eckel J,"

Phrase: "Mller H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Niggemann J,"

Phrase: "Fujiwara T,"

Phrase: "Horikoshi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kiehn R 1997 Troglitazone-induced insulin sensitizing in cardiac muscle"

Phrase: "of diabetic ZDF-rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "correlates to inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "redistribution of membrane-asssociated PKC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332620:Redistribution [Functional Concept]
Processing 00000000.tx.306: Diabetes [Suppl 1] 46:149A (Abstract) Kolter T, Uphues I, Eckel J 1997 Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "[Suppl 1"

Phrase: "] 46"

Phrase: ":"

Phrase: "149A"

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")"

Phrase: "Kolter T,"

Phrase: "Uphues I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Eckel J 1997 Molecular analysis of insulin resistance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1513380:Molecular Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "in isolated ventricular cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0225828:Cardiomyocytes [Cell]

Phrase: "of obese Zucker rats."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.307: Am J Physiol 273:E59E67 Zhang B, Szalkowski D, Diaz E, Hayes N, Smith R, Berger J 1994 Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinediones-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myocytes. 

Phrase: "Am"

Phrase: "J Physiol 273"

Phrase: ":"

Phrase: "E59E67 Zhang B,"

Phrase: "Szalkowski D,"

Phrase: "Diaz E,"

Phrase: "Hayes N,"

Phrase: "Smith R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Berger J 1994 Potentiation of insulin stimulation of phosphatidylinositol 3-kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "by thiazolidinediones-derived antidiabetic agents"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   890   C3273907:Thiazolidinedione Antidiabetic Agent [Chemical Viewed Functionally]
   861   C0935929:Antidiabetic Agents [Pharmacologic Substance]
           antidiabetic
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]

Phrase: "in Chinese hamster ovary cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human insulin receptors"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   966   C1448132:insulin receptor, human [Amino Acid, Peptide, or Protein,Receptor]
   901   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   867 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "L6 myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596981:Myocytes [Cell]
Processing 00000000.tx.308: J Biol Chem 269:2573525741[Abstract/Free FullText] Berger J, Biswas C, Hayes N, Ventre J, Wu M, Doebber TW 1996 An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissues. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2573525741"

Phrase: "[Abstract/Free FullText"

Phrase: "] Berger J,"

Phrase: "Biswas C,"

Phrase: "Hayes N,"

Phrase: "Ventre J,"

Phrase: "Wu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Doebber TW 1996"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039260:TW [Geographic Area]
   827   C0332293:TW [Therapeutic or Preventive Procedure]

Phrase: "An antidiabetic thiazolidinedione"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   861   C1257987:Thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   861   C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "potentiates"

Phrase: "insulin stimulation of glycogen synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in rat adipose tissues."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0001527:Adipose tissues [Tissue]
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.309: Endocrinology 137:19841990[Abstract] Sizer KM, Smith CL, Jacob CS, Swanson ML, Bleasdale JE 1994 Pioglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3L1 adipocytes by inhibiting a negative control mechanism. 

Phrase: "Endocrinology 137"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "19841990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sizer KM,"

Phrase: "Smith CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Jacob CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Swanson ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Bleasdale JE 1994 Pioglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0071097:pioglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "insulin-induced activation of phosphoinositide 3-kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "in 3T3L1 adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206131:Adipocytes [Cell]

Phrase: "by inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "a negative control mechanism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
   734   C1639518:% negative control [Quantitative Concept]
   734   C1947986:Negative Control [Conceptual Entity]
Processing 00000000.tx.310: Mol Cell Endocrinol 103:112[Medline] Ishii S, Wasaki M, Ohe T, Ueno H, Tanaka H 1996 MCC-555: a highly potent thiazolidinedione lacking hematological and cardiac side-effects. 

Phrase: "Mol Cell Endocrinol 103"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "112"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ishii S,"

Phrase: "Wasaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ohe T,"

Phrase: "Ueno H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tanaka H 1996 MCC-555"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0758974:MCC-555 [Organic Chemical,Pharmacologic Substance]
   804   C0033727:H+ [Element, Ion, or Isotope]
   804   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441932:H+ [Classification]
   804   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "a highly potent thiazolidinedione"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   827   C1257987:Thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   827   C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "hematological"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   928   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   928   C0200627:HEMATOLOGY [Laboratory Procedure]
   900 E C0205488:Haematologic [Functional Concept]

Phrase: "and"

Phrase: "cardiac side-effects."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0001688:side effects [Functional Concept]
   867 E C0879626:Side Effect [Pathologic Function]
   827   C0441987:Side [Spatial Concept]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.311: Diabetes [Suppl 2] 45:141A (Abstract) Eckel J, Pandalis G, Reinauer H 1983 Insulin action on the glucose transport system in isolated cardiocytes from adult rat. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "[Suppl 2"

Phrase: "] 45"

Phrase: ":"

Phrase: "141A"

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")"

Phrase: "Eckel J,"

Phrase: "Pandalis G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Reinauer H 1983 Insulin action on the glucose transport system"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C1719133:Glucose/Insulin [Quantitative Concept]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0441472:Action [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C3266814:Action [Activity]

Phrase: "in isolated cardiocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0225828:Cardiocyte [Cell]
   827   C2333889:Cardiocyte [Classification]

Phrase: "from adult rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.312: Biochem J 212:385392[Medline] Russ M, Eckel J 1995 Insulin action on cardiac glucose transport: studies on the role of protein kinase C. 

Phrase: "Biochem J 212"

Phrase: ":"

Phrase: "385392"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Russ M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Eckel J 1995 Insulin action on cardiac glucose transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1719133:Glucose/Insulin [Quantitative Concept]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0441472:Action [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C3266814:Action [Activity]

Phrase: ":"

Phrase: "studies on the role of protein kinase C."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]
Processing 00000000.tx.313: Biochim Biophys Acta 1265:7378[Medline] Liu LS, Spelleken M, Rhrig K, Hauner H, Eckel J 1998 Tumour necrosis factor (TNF)- acutely inhibits insulin signaling in human adipocytes: implication of the p80 TNF receptor. 

Phrase: "Biochim Biophys Acta 1265"

Phrase: ":"

Phrase: "7378"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu LS,"

Phrase: "Spelleken M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rhrig K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hauner H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Eckel J 1998 Tumour necrosis factor (TNF)- acutely"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   845   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   845   C1323304:tumor necrosis factor [Molecular Function]
   845   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0333516:Tumor necrosis [Neoplastic Process]
   795   C0027540:Necrosis [Organ or Tissue Function]
   795   C0027651:Tumor [Neoplastic Process]
   795   C1334928:Necrosis [Finding]
   795   C1521761:Factor [Functional Concept]
   795   C1578706:Tumor [Intellectual Product]
   795   C2827422:Factor [Conceptual Entity]
   795   C3273930:Tumor [Finding]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin signaling in human adipocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037083:Signaling [Cell Function]
   760   C3537152:signaling [Biologic Function]

Phrase: ":"

Phrase: "implication of the p80 TNF receptor."
Processing 00000000.tx.314: Diabetes 47:515522[Abstract] Wichelhaus A, Russ M, Petersen S, Eckel J 1994 G protein expression and adenylate cyclase regulation in ventricular cardiomyocytes from STZ-diabetic rats. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "515522"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wichelhaus"

Phrase: "A,"

Phrase: "Russ M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Petersen S,"

Phrase: "Eckel J 1994 G protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "adenylate cyclase regulation in ventricular cardiomyocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "from STZ-diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]
Processing 00000000.tx.315: Am J Physiol 267:H548H555 Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn, CR 1994 Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. 

Phrase: "Am"

Phrase: "J Physiol 267"

Phrase: ":"

Phrase: "H548H555 Cheatham B,"

Phrase: "Vlahos CJ,"

Phrase: "Cheatham L,"

Phrase: "Wang L,"

Phrase: "Blenis J,"

Phrase: "Kahn,"

Phrase: "CR 1994 Phosphatidylinositol 3-kinase activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "required for insulin stimulation of pp70 S6 kinase,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1419024:S6 [Gene or Genome]
   744   C1419741:S6 [Gene or Genome]
   744   C1514873:Required [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1861424:S6 [Gene or Genome]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
   744   C2348600:S6+ [Element, Ion, or Isotope]

Phrase: "DNA synthesis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "glucose transporter translocation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]
   734   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.316: Mol Cell Biol 14:49024911[Abstract] Mukherjee R, Jow L, Croston GE, Paterniti JR Jr 1997 Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPAR 2 vs. 

Phrase: "Mol Cell Biol 14"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "49024911"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mukherjee R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Jow L,"

Phrase: "Croston GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: "Paterniti JR Jr 1997 Identification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0020792:Identification [Mental Process]
   804   C0205396:Identification [Qualitative Concept]

Phrase: "characterization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "tissue distribution of human peroxisome proliferator-activated receptor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0040287:Tissue Distribution [Quantitative Concept]
   770   C0220927:tissue distribution [Functional Concept]
   767   C0440744:Human tissue [Tissue]
   744   C0040300:Tissue [Tissue]
   744   C0520511:distribution [Idea or Concept]
   744   C1547928:Tissue [Intellectual Product]
   744   C1704711:Distribution [Functional Concept]

Phrase: "(PPAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   982   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   982   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "isoforms PPAR 2"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   883   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   883   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   799   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1879547:Activated [Activity]
   799   C3546463:peroxisomal [Cell Component]
   791   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   766 E C1515877:Activate [Functional Concept]
   727 E C0752063:Peroxisomes [Cell Component]
   727 E C2984308:Peroxisome [Functional Concept]

Phrase: "vs."
Processing 00000000.tx.317: PPAR1 and activation with retinoid X receptor agonists and antagonists. 

Phrase: "PPAR1"

Phrase: "and"

Phrase: "activation with retinoid X receptor agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1514758:Receptor Activation [Cell Function]
   753   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "antagonists."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0243076:antagonists [Chemical Viewed Functionally]
   966 E C0231491:Antagonist [Organ or Tissue Function]
   893 E C0680242:antagonism [Social Behavior]
Processing 00000000.tx.318: J Biol Chem 272:80718076[Abstract/Free FullText] Reginato MJ, Rangwala SM, Bailey ST, Krakow SL, Ishii S, Tanaka H, Lazar M A novel antidiabetic thiazolidinedione. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "80718076"

Phrase: "[Abstract/Free FullText"

Phrase: "] Reginato MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Rangwala SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Bailey ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Krakow SL,"

Phrase: "Ishii S,"

Phrase: "Tanaka H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lazar M A novel antidiabetic thiazolidinedione."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   799   C1257987:Thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   799   C3537039:Thiazolidinedione [Pharmacologic Substance]
Processing 00000000.tx.319: Keystone Symposium on Nuclear Receptor Gene Family, Incline Village NV, 1998 (Abstract 349) Mizukami J, Taniguchi T 1997 The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR and CBP. 

Phrase: "Keystone Symposium on Nuclear Receptor Gene Family,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0086047:symposium [Human-caused Phenomenon or Process]

Phrase: "Incline Village NV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027951:NV [Geographic Area]
   827   C3540591:NV [Idea or Concept]

Phrase: "1998"

Phrase: "(Abstract 349"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]

Phrase: ")"

Phrase: "Mizukami J,"

Phrase: "Taniguchi T 1997"

Phrase: "The antidiabetic agent thiazolidinedione"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   827   C1257987:Thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   827   C3537039:Thiazolidinedione [Pharmacologic Substance]
   734   C0935929:Anti-diabetic Agent [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "the interaction between PPAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "CBP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539643:CBP [Gene or Genome]
Processing 00000000.tx.320: Biochem Biophys Res Commun 240:6164[CrossRef][Medline] el Kebbi IM, Roser S, Pollet RJ 1994 Regulation of glucose transport by Pioglitazone in cultured muscle cells. 

Phrase: "Biochem Biophys Res Commun 240"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "6164"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] el Kebbi IM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539078:IM [Idea or Concept]

Phrase: "Roser S,"

Phrase: "Pollet RJ 1994 Regulation of glucose transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C2612126:regulation of glucose transport [Cell Function]
   804   C1523074:regulation of transport [Cell Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by Pioglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071097:pioglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "in cultured muscle cells."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   901   C0596981:Muscle Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.321: Metabolism 43:953958[Medline] Ciaraldi TP, Huber-Knudsen K, Hickman M, Olefsky JM 1995 Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents. 

Phrase: "Metabolism 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "953958"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ciaraldi TP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]

Phrase: "Huber-Knudsen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Hickman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Olefsky JM 1995 Regulation of glucose transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C2612126:regulation of glucose transport [Cell Function]
   804   C1523074:regulation of transport [Cell Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in cultured muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   901   C0596981:Muscle Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "by novel hypoglycemic agents."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0020616:Hypoglycemic Agents [Pharmacologic Substance]
           Hypoglycaemic
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.322: Metabolism 44:976982[Medline] Sandouk T, Reda D, Hofmann C 1993 The antidiabetic agent Pioglitazone increases expression of glucose transporters in 3T3F442A cells by increasing mesenger ribonucleic acid transcript stability. 

Phrase: "Metabolism 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "976982"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sandouk T,"

Phrase: "Reda D,"

Phrase: "Hofmann C 1993"

Phrase: "The antidiabetic agent Pioglitazone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0071097:pioglitazone [Organic Chemical,Pharmacologic Substance]
   734   C0935929:Anti-diabetic Agent [Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "expression of glucose transporters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in 3T3F442A cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by increasing mesenger ribonucleic acid transcript stability."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0205360:Stability [Qualitative Concept]
   799   C2347098:Stability [Qualitative Concept]
   727 E C1547311:Stable [Intellectual Product]
Processing 00000000.tx.323: Endocrinology 133:352359[Abstract] Wu Z, Xie Y, Morrison RF, Bucher NLR, Farmer SR 1998 PPAR induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBP during the conversion of 3T3 fibroblasts into adipocytes. 

Phrase: "Endocrinology 133"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "352359"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wu Z,"

Phrase: "Xie Y,"

Phrase: "Morrison RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Bucher NLR,"

Phrase: "Farmer SR 1998 PPAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   859   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   859   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the insulin-dependent glucose transporter GLUT4 in the absence of C/EBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C1420175:GLUT4 [Gene or Genome]
   736   C2982484:GLUT4 [Gene or Genome]

Phrase: "during the conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439836:Conversion [Functional Concept]

Phrase: "of 3T3 fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "into adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]
Processing 00000000.tx.324: J Clin Invest 101:2232[Abstract/Free FullText] Kobayashi M, Iwanishi M, Egawa K, Shigeta Y 1992 Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "101"

Phrase: ":"

Phrase: "2232"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kobayashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Iwanishi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Egawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Shigeta Y 1992 Pioglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0071097:pioglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "insulin sensitivity by activating insulin receptor kinase."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0920563:Insulin Sensitivity [Pathologic Function]
   774   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   774   C0597362:receptor sensitivity [Functional Concept]
   774   C1334133:INSULIN RECEPTOR [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.325: Diabetes 41:476483[Abstract] Iwanishi M, Kobayashi M 1993 Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats. 

Phrase: "Diabetes 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "476483"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Iwanishi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kobayashi M 1993 Effect of pioglitazone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin receptors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "of skeletal muscles"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0242692:Skeletal muscles, NOS [Tissue]
   966 E C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscles [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   861   C1995013:Muscles [Body Part, Organ, or Organ Component]
   777 E C0442025:Muscular [Spatial Concept]

Phrase: "from high-fat-fed rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
Processing 00000000.tx.326: Metabolism 42:10171021[Medline] Kellerer M, Kroder G, Tippmer S, Berti L, Kiehn R, Mosthaf L, Hring H 1994 Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. 

Phrase: "Metabolism 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "10171021"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kellerer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kroder G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Tippmer S,"

Phrase: "Berti L,"

Phrase: "Kiehn R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mosthaf L,"

Phrase: "Hring H 1994 Troglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "glucose-induced insulin resistance of insulin receptor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   774   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   774   C1334133:INSULIN RECEPTOR [Gene or Genome]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in rat-1 fibroblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0016030:Fibroblasts [Cell]
   734   C1514732:Rat-1 [Cell]
Processing 00000000.tx.327: Diabetes 43:447453[Abstract] Dhand R, Hiles I, Panayotou G, Roche S, Fry MJ, Gout I, Totty N, Truong O, Vicendo P, Yonezawa K, Kasuga M, Courtneidge SA, Waterfield MD 1994 PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. 

Phrase: "Diabetes 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "447453"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Dhand R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hiles I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Panayotou G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Roche S,"

Phrase: "Fry MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Gout I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Totty N,"

Phrase: "Truong O,"

Phrase: "Vicendo P,"

Phrase: "Yonezawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kasuga M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Courtneidge SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Waterfield MD 1994 PI 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   833 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a dual specificity enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ":"

Phrase: "autoregulation by an intrinsic protein-serine kinase activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0019868:Autoregulation [Biologic Function]
Processing 00000000.tx.328: EMBO J 13:522533[Abstract] Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H 1997 Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor- in humans. 

Phrase: "EMBO J 13"

Phrase: ":"

Phrase: "522533"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Auboeuf D,"

Phrase: "Rieusset J,"

Phrase: "Fajas L,"

Phrase: "Vallier P,"

Phrase: "Frering V,"

Phrase: "Riou JP,"

Phrase: "Staels B,"

Phrase: "Auwerx J,"

Phrase: "Laville M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vidal H 1997 Tissue distribution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0040287:Tissue Distribution [Quantitative Concept]
   840   C0220927:tissue distribution [Functional Concept]
   804   C0040300:Tissue [Tissue]
   804   C0520511:distribution [Idea or Concept]
   804   C1547928:Tissue [Intellectual Product]
   804   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "quantification of the expression of mRNAs of peroxisome proliferator-activated receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "liver X receptor-"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1612060:liver X receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1421546:X RECEPTOR [Gene or Genome]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.329: Diabetes 46:13191327[Abstract] Vidal-Puig A, Linan-Jimenez M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE 1996 Regulation of PPAR gene expression by nutrition and obesity in rodents. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "13191327"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Vidal-Puig A,"

Phrase: "Linan-Jimenez M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Lowell BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Hamann A,"

Phrase: "Hu E,"

Phrase: "Spiegelman B,"

Phrase: "Flier JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Moller DE 1996 Regulation of PPAR gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   738   C0851285:Regulation [Governmental or Regulatory Activity]
   738   C1327622:Regulation [Biologic Function]

Phrase: "by nutrition"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0028707:Nutrition [Biomedical Occupation or Discipline]
  1000   C0392209:nutrition [Organism Attribute]
  1000   C1442959:Nutrition [Organism Function]
   928 E C1521739:Nutritional [Qualitative Concept]
   928 E C2707262:Nutritional [Clinical Attribute]

Phrase: "and"

Phrase: "obesity in rodents."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1963185:Obesity [Finding]
Processing 00000000.tx.330: J Clin Invest 97:25532561[Abstract/Free FullText] Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W 1996 Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR, - and - in the adult rat. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "25532561"

Phrase: "[Abstract/Free FullText"

Phrase: "] Braissant O,"

Phrase: "Foufelle F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Scotto C,"

Phrase: "Dauca M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wahli W 1996 Differential expression of peroxisome proliferator-activated receptors (PPARs)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0597360:receptor expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "tissue distribution of PPAR,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0040287:Tissue Distribution [Quantitative Concept]
   778   C0220927:tissue distribution [Functional Concept]
   748   C0040300:Tissue [Tissue]
   748   C0520511:distribution [Idea or Concept]
   748   C1547928:Tissue [Intellectual Product]
   748   C1704711:Distribution [Functional Concept]

Phrase: "-"

Phrase: "and - in the adult rat."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0001675:Adult [Age Group]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1515981:And [Idea or Concept]
   760   C1706450:Adult [Human]
Processing 00000000.tx.331: Endocrinology 137:354366[Abstract] Zhu Y, Alvares K, Huang Q, Rao MS, Reddy JK 1993 Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. 

Phrase: "Endocrinology 137"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "354366"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zhu Y,"

Phrase: "Alvares K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Huang Q,"

Phrase: "Rao MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Reddy JK 1993 Cloning of a new member"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0009015:Cloning [Research Activity]

Phrase: "of the peroxisome proliferator-activated receptor gene family"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C1517488:Gene Family [Gene or Genome]
   799   C0015576:Family [Family Group]
   799   C1704727:Family [Conceptual Entity]
   734   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   727 E C0241888:Familial [Functional Concept]

Phrase: "from mouse liver."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1517914:Mouse Liver [Tissue]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.332: J Biol Chem 268:2681726820[Abstract/Free FullText] Hayakawa T, Shiraki T, Morimoto T, Shii K, Ikeda H 1996 Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) Zucker rats. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2681726820"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hayakawa T,"

Phrase: "Shiraki T,"

Phrase: "Morimoto T,"

Phrase: "Shii K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ikeda H 1996 Pioglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0071097:pioglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "improves"

Phrase: "insulin signaling defects in skeletal muscle"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0243067:defects [Functional Concept]
   719 E C1457869:Defect [Functional Concept]
   719 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "from Wistar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700262:Wistar [Mammal]

Phrase: "fatty"

Phrase: "(fa/fa) Zucker rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C2700303:Zucker [Mammal]
Processing 00000000.tx.333: Biochem Biophys Res Commun 223:439444[CrossRef][Medline] Hirshman MF, Fagnant PM, Horton ED, King PA, Horton ES 1995 Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes. 

Phrase: "Biochem Biophys Res Commun 223"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "439444"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hirshman MF,"

Phrase: "Fagnant PM, Horton ED,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3538926:ED [Idea or Concept]

Phrase: "King"

Phrase: "PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "Horton ES 1995 Pioglitazone treatment for 7 days"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "failed to correct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231175:Failed [Functional Concept]
   790   C2349182:Correct [Qualitative Concept]

Phrase: "the defect in glucose transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0342750:Glucose transport defect [Disease or Syndrome]
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "glucose transporter translocation in obese Zucker rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040715:Translocation [Cell or Molecular Dysfunction]
   748   C2987521:Translocation [Activity]

Phrase: "(fa/fa) skeletal muscle plasma membranes."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0007603:Plasma Membranes [Cell Component]
   799   C0025255:Membranes [Tissue]
   799   C0032105:Plasma [Body Substance]
   799   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   766 E C0596901:Membrane [Cell Component]
   766 E C1706182:Membrane [Manufactured Object]
   716 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.334: Biochem Biophys Res Commun 208:835845[CrossRef][Medline] Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-- and obesity-induced insulin resistance. 

Phrase: "Biochem Biophys Res Commun 208"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "835845"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hotamisligil GS,"

Phrase: "Peraldi P,"

Phrase: "Budavari A,"

Phrase: "Ellis R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "White MF,"

Phrase: "Spiegelman BM 1996 IRS-1-mediated inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   842   C1514761:Receptor Inhibition [Cell Function]
   791   C0021467:Inhibition [Mental Process]
   791   C0021469:Inhibition [Molecular Function]
   791   C1628982:% inhibition [Quantitative Concept]
   791   C3463820:Inhibition [Activity]
   720 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of insulin receptor tyrosine kinase activity"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   937   C0915518:insulin receptor tyrosine kinase [Amino Acid, Peptide, or Protein,Enzyme]
   911   C1150623:insulin receptor activity [Molecular Function]
   897   C1145751:insulin activity [Molecular Function]
   884   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   875   C1152633:receptor activity [Molecular Function]
   840   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1150423:kinase activity [Molecular Function]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "in TNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "-"

Phrase: "-"

Phrase: "and"

Phrase: "obesity-induced insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   861   C0021655:Insulin Resistance [Pathologic Function]
   861   C2700570:INSULIN RESISTANCE [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0237834:Resistance [Mental Process]
   812   C1514892:Resistance [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   741 E C0332325:Resistant [Functional Concept]
   741 E C1550464:resistent [Idea or Concept]
   741 E C2827757:RESISTANT [Laboratory or Test Result]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.335: Science 271:665668[Abstract] Peraldi P, Xu M, Spiegelman BM 1997 Thiazolidinediones block tumor necrosis factor--induced inhibition of insulin signaling. 

Phrase: "Science 271"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "665668"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Peraldi P,"

Phrase: "Xu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Spiegelman BM 1997 Thiazolidinediones"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   779 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   779 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "--"

Phrase: "induced inhibition of insulin signaling."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]
Processing 00000000.tx.336: J Clin Invest 100:18631869[Abstract/Free FullText]

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "100"

Phrase: ":"

Phrase: "18631869"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

